Chronic morphine treatment-modulated trafficking of AMPA receptors: a potential mechanism for drug addiction by Kam, Yuet Fong
  
 
 
CHRONIC MORPHINE TREATMENT-MODULATED 
TRAFFICKING OF AMPA RECEPTORS:  
A POTENTIAL MECHANISM FOR DRUG ADDICTION 
 
A DISSERTATION  
SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL 
OF THE UNIVERSITY OF MINNESOTA 
 BY 
 
Yuet Fong KAM  
  
IN PARTIAL FULFILLMENT OF THE REQUIREMENTS 
FOR THE DEGREE OF 
DOCTOR OF PHILOSOPHY 
 
 
 
Ping-Yee Law, Ph.D., Advisor 
 
August, 2012 
  
 
 
 
 
 
© YUET FONG KAM 2012
  i 
ACKNOWLEDGMENTS 
I am very grateful to my advisor, Dr. Ping Yee Law, for providing me an 
opportunity to conduct my PhD work at the University of Minnesota.  Dr. Law offered me 
a lot of resources and support to pursue and develop my thesis work.  I would like to 
thank my committee members, Drs. Paulo Kofuji, Dezhi Liao, Jonathan Marchant and 
Stanley Thayer for their valuable comments and suggestions on my research work.  
Further, I am indebted to Dr. Horace H. Loh who always supports my research work. 
My thesis research would not be possible without the help from Drs. Horace H. 
Loh and Dezhi Liao who provided me important tools and resources in their laboratories.  
Moreover, I thank many people who have given their kind help to my work, especially 
Cherky Kibaly, Lei Zhang, Jinghua Xi and Hui Zheng. 
My PhD study was funded through several grants from the National Institutes of 
Health to D.L., H.H.L. and P.Y.L., the University of Minnesota Medical School and 
Minnesota Medical Foundation (Milne Brandenberg Award), and the University of 
Minnesota Graduate School (Doctoral Dissertation Fellowship). I acknowledged the 
Department of Pharmacology, University of Minnesota, for providing me financial support 
to attend Neuroscience Meeting 2010 in San Diego, California.  
Finally, I would like to thank my family members, especially my parents and sister 
Ida Kam, who provided a lot of support to me while I was conducting my study overseas, 
which is always challenging and difficult.  Lastly, I am glad to go through much hardship 
during my PhD study while being supported by my husband, Martin Tsui, in Minnesota! 
 
  ii 
ABSTRACT 
Morphine is the benchmark analgesic for treating chronic pain. However, 
its clinical uses are hindered by its highly addictive nature, as chronic treatment 
with the drug will produce physical and psychological dependence upon the 
cessation of use. Drug craving is the main driving force for relapse after 
prolonged periods of abstinence, and represents an enormous challenge for the 
treatment of drug addiction. Since addiction is a long-term behavioral alteration, it 
is believed that addictive drugs produce reorganization of specific neural circuits 
and adjustment of synaptic strength. The underlying mechanisms of these neural 
adaptations may represent a promising target for prevention and/or treatment of 
addiction, but the detailed mechanisms of these processes remain unclear. 
Therefore, the main goals of this work are to delineate signaling pathways 
controlling morphine-induced neural adaptations and investigate their functional 
role in opiate addictive behaviors.   
 α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors 
are postsynaptic glutamate receptors, and are responsible for mediating most 
excitatory synaptic transmission under normal conditions. More importantly, the 
dynamic localization of AMPA receptors plays a critical role for modifying 
synaptic strength and synaptic morphology. Here, I hypothesized that regulation 
of AMPA receptor trafficking by morphine treatment underlies the drug-induced 
neural modulation implicated in the addiction process. Hence, the first part of this 
dissertation research examined whether and how chronic exposure to morphine 
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modulates trafficking of surface GluR1 (a subunit of AMPA receptors) in primary 
hippocampal neurons. Using live-cell imaging techniques together with 
biochemical studies, I demonstrated that chronic exposure to morphine induced a 
significant loss of synaptic and extrasynaptic GluR1 by internalization. In 
mechanistic studies, I found that the GluR1 internalization was attributed to 
dephosphorylation of the receptor subunit at Ser845 following morphine treatment, 
but it did not result from altered neural network or NMDA receptor activation. 
Moreover, dephosphorylation of GluR1 at Ser845 was found to require morphine-
evoked calcineurin activation. Therefore, calcineurin-dependent 
dephosphorylation of AMPA receptor and subsequent AMPA receptor 
internalization provides a novel mechanism for opioid-induced neural 
adaptations.  
The second part of this dissertation research attempted to link morphine’s 
effects on GluR1 phosphorylation and endocytosis to addictive behavior, 
especially formation of memory for the environmental context of the drug 
experience, because recall of this memory by encountering the drug-paired cues 
triggers relapse to drug seeking. In this approach, a mutant mouse line was 
used, in which GluR1 at Ser845 was mutated to Ala (S845A) leading to an 
absence of morphine-induced GluR1 endocytosis. A behavioral test, conditioned 
place preference (CPP), was carried out to assess the ability of morphine to 
produce a positive association with environmental cues. I found that S845A mice 
were significantly slower to acquire morphine-induced CPP when compared to 
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wild types (WT). This decreased sensitivity to morphine CPP in mutants was 
neither related to contextual memory deficits or abnormal locomotor activity, as 
there was no difference between WT and S845A mice in the contextual memory 
acquisition in the Morris water maze test or locomotion with or without morphine 
injection. To examine the persistence of morphine-associated contextual memory 
in the mutant mice, I also performed extinction tests on mice conditioned with 10 
mg/kg morphine for four sessions, by which both WT and S845A mice exhibited 
similar CPP responses. Interestingly, a prolonged extinction was observed in 
S845A mutant mice, suggesting the S845A mutation either impaired the learning 
of the new conditioning or prolonged the retention of the old conditioning. 
Nevertheless, these results suggest that an alteration in GluR1 phosphorylation 
at Ser845 and subsequent receptor endocytosis/insertion are involved in 
acquisition and extinction of morphine CPP.  
Altogether, the present findings indicate that calcineurin-mediated GluR1-
S845 dephosphorylation is required for morphine-induced internalization of 
GluR1-containing AMPA receptors, providing a molecular basis for the drug-
induced neural modulation. This work also suggests that this regulation of GluR1 
phosphorylation and trafficking by morphine is involved in the modulation of the 
drug-associated contextual memory, which reflects the involvement of AMPA 
receptor trafficking in the mechanisms underlying opiate-seeking behaviors. 
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CHAPTER 1 
INTRODUCTION 
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1.1 An opiate analgesic: morphine 
 Opium has been widely used for both relieving pain and producing sedation since 
ancient times, and hence it is recognized as narcotic analgesic. It indeed is extracted 
from the dried latex of the seed pods of the opium poppy (Papaver Somniferum) (Kirby, 
1967). A significant contribution to the opium processing occurred in the nineteenth 
century. The main constituents found in opium are a group of nitrogenous basic 
substances that are poorly soluble in water but readily dissolve in alcohol, named 
alkaloids (Kirby, 1967). Raw opium contains more than 20 alkaloids and the most 
abundant one, morphine, was firstly isolated by a German pharmacist, Friedrich 
Sertürner, in 1804 (Kirby, 1967; Luch, 2009). Later, morphine was discovered to be the 
most active component responsible for the opium’s analgesic property. Nowadays, 
morphine is widely regarded as a benchmark of analgesics to treat both acute and 
chronic severe pain, such as labor pain, cancer pain, severe ulcerative colitis and 
hepatic cirrhosis (Foye 1989; Carr et al., 1994). Other alkaloids such as codeine, 
papaverine and noscapine with weak or no painkilling activities are prescribed for 
relieving mild pain, spasms of smooth muscles and cough (Eddy et al., 1968). Although 
thebaine has no therapeutic value, it is a key synthetic intermediate for the production of 
various compounds, such as oxycodone, etorphine, naloxone and naltrexone (Novak et 
al., 2000). All natural alkaloids in opium and any semi-synthetic derivatives of opium are 
termed as opiates, while opioid describes any natural, semi-synthetic or synthetic 
compounds with opiate-like activities.  
 
1.2 Morphine addiction and other adverse effects 
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In comparison with other alkaloids from opium, morphine is a potent opiate 
analgesic but is also a highly addictive substance. Drug addiction is generally 
considered as the compulsive use of a drug, despite of any adverse physical and 
psychosocial consequences (Everitt et al., 2001). The underlying mechanism for this 
“abnormal” behavior involves the development of tolerance, physical dependence and 
psychological dependence upon repetitive exposure to the drug (Haefely, 1986). With 
chronic administration of morphine, tolerance is commonly encountered when the initial 
dose of the drug loses its efficacy over time and increasing doses are required for 
achieving the equivalent effect (Koob et al., 1988; Bhargava, 1991; Bodnar, 2011). The 
escalation of drug intake not only causes severe complications, but also has a higher 
potential leading to addiction. Meanwhile, body compensations or physiological 
adaptations to the morphine’s action occur. Such body compensation will develop 
physical dependence that displays through the withdrawal symptoms once 
discontinuation of morphine use or exposure to antagonists, like naloxone (Nestler et al., 
1993). The withdrawal symptoms include a variety of extremely unpleasant body 
reactions, including watery eyes, runny nose, sweating, nausea and vomiting, diarrhea, 
tremors, restlessness, irritability, yawning, insomnia, dysphoria, increased heart rate and 
blood pressure, as well as intense drug craving (Koob et al., 1992). Nevertheless, 
tolerance and physical dependence/withdrawal symptoms no longer last in detoxified 
drug addicts. Instead, psychological dependence like drug craving is still present 
(O’Brien et al., 1998). The addicts often suffer numerous psychological disorders, such 
as depression, anxiety, low self-esteem, confusion and paranoia (de Jong et al., 2006). 
As drug craving is a main driving force for ongoing drug use or relapse even after years 
of drug abstinence, it makes the biggest problem for the treatment of drug addiction and 
limits morphine’s medical use. Apart from addictive nature, overdose of morphine and 
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other opiate drugs results in other complications as well. For instance, as they have a 
major influence on the smooth muscle and glandular secretions of the respiratory and 
gastrointestinal tracts, they will elicit respiratory depression and constipation. In addition, 
pupils will constrict that is one of the most recognized signs of opiate use (Goldfrank, 
2006). All of the above physiological effects of opiate drugs are primarily mediated by 
specific opioid receptors (Harrison et al., 1998).  
 
1.3 Opioid receptors 
1.3.1 Opioid receptor classification 
Opioid receptors belong to the superfamily of G protein-coupled receptors 
(GPCR), characterized by seven transmembrane helices and coupled with heterotrimeric 
guanine nucleotide-binding proteins (G proteins). The seven transmembrane domains of 
receptors are linked by three extracellular loops and three intracellular loops with an 
extracellular amino-terminus (N-terminus) and intracellular carboxyl-terminus (C-
terminus). Based on previous studies examining their first ligand bindings and 
anatomical locations, they were classified into three main subtypes: μ (morphine), κ 
(ketocyclazocine) and δ (vas deferens) (Dhawan et al., 1996). Later, a cDNA of an 
orphan receptor bearing substantial homology to the classical opioid receptors was 
cloned and known as opioid receptor-like (ORL1) receptor (Wick et al., 1994). To 
compare amino acid sequences of proteins, the three subtypes of opioid receptors are 
about 60% identical to each other, with the greatest homology found in the 
transmembrane (73-76%) and intracellular loops (86-100%) regions. The N-terminus (9-
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10%), extracellular loops (14-72%) and the C-terminus (14-20%) are not well conserved 
among them (Chen et al., 1993).  
 
1.3.2 μ-opioid receptor and its distribution 
The μ-opioid receptor is the most important for at least two reasons. First, 
morphine predominantly binds to the μ-receptor subtype with an affinity of nanomolar Ki 
values, but has a low preference for δ- and κ-receptors in a submicromolar range 
(Raynor et al., 1994). In addition, μ-opioid receptors are required for both the wanted 
and unwanted effects of morphine on the central nervous system and certain visceral 
organs. For examples, studies on μ-opioid receptor deficient mice revealed that no 
analgesic response was observed in mutant animals subcutaneously injected with 
morphine at doses that classically produce a strong analgesia in wild types (up to 50 
mg/kg) (Matthes et al., 1996; Sora et al., 1997 and Schuller et al., 1999). Roy et al. 
(1998) indicated that morphine at a dose inducing constipation in wild type mice had no 
influence on the gastrointestinal motility in μ-opioid receptor knockout mice. In fact, the 
localization of μ-opioid receptors can be inferred by the pharmacological actions of 
morphine, and vice versa. μ-Opioid receptors are distributed in several regions involved 
in nociceptive transmission, such as periaqueductal grey of the midbrain, the dorsal horn 
of the spinal cord and dorsal root ganglion (DRG) (Delfs et al., 1994; Zastawny et al., 
1994). They are also found to locate throughout different brain regions such as 
amygdala, neocortex, thalamus, hypothalamus, caudate putamen of basal ganglia, 
hippocampus, ventral tegmental area (VTA) and nucleus accumbens (Mansour et al., 
1995). Among them, amygdala, neocortex, thalamus and caudate putamen of basal 
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ganglia are associated with sensory-motor function and their signaling integration 
(Mircea et al., 1988; Mansour et al., 1994), while VTA and nucleus accumbens are a 
well-known reward circuitry area for addiction (Di Chiara and Imperato, 1988). 
Hippocampus, a vital area for contextual learning and memory consolidation, recently 
has been suggested to regulate the rewarding effects of abused drugs (Fan et al., 1999; 
Vorel et al., 2001). The distribution of the μ-opioid receptors in these brain regions hence 
confirms their importance for morphine-induced emotional tone, locomotion and 
addiction. Similarly, other undesirable effects of morphine such as nausea, respiratory 
depression, heart rate change and constipation arise from both central and peripheral 
sites of action, as the autonomic nervous system (e.g. area postrema, nucleus 
ambiguus, dorsal motor nucleus of vagus and nucleus of the solitary tract) and the 
gastrointestinal tract can express the μ-opioid receptors (Mansour et al., 1995, Holzer, 
2009, Hassen et al., 1984).   
 
1.3.3 μ-opioid receptor signaling 
As mentioned above, opioid receptors are a member of GPCR superfamily and 
transduce cellular signals via coupling to inhibitory Gi/Go proteins. Indeed, all G protein 
including Gi/o will separate from the receptors upon stimulation and in turn dissociate into 
two functional units, Gα-GTP and Gβγ dimer. Both of these functional molecules are 
responsible for mediating activities of downstream effectors (Hepler and Gilman, 1992). 
Stimulation of μ-opioid receptors by morphine typically requires Gαi/o proteins to induce: 
(i) decrease in the activity of adenylyl cyclase (AC) and the level of cyclic adenosine 
monophosphate (cAMP); (ii) inhibition of voltage-gated Ca2+ channels, and (iii) 
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stimulation of K+ channel (Sharma et al., 1977; Hescheler et al., 1987; North et al., 1987) 
(Fig. 1.1). However, ample evidence later have demonstrated that the μ-opioid receptor-
coupled inhibitory AC and cAMP signaling were reversed to basal level upon persistent 
treatment with morphine and even up-regulated after the removal of morphine or the 
addition of antagonist. This dual regulation of AC signaling was hypothesized to 
correlate with opioid tolerance and dependence (Sharma et al., 1975, Collier and 
Francis, 1975; Ueda and Ueda, 2009). There are reports about mechanisms of the 
counterbalancing increase in cAMP level. For instance, chronic exposure to morphine 
led to phosphorylation of AC and Gβγ as well as membrane translocation of 
PKCγ (protein kinase C) (Chakrabarti and Gintzler, 2003; Mao et al., 1995). Moreover, 
the free Gβγ dimer from Gi proteins was found to induce not only stimulation of AC2 
isoform (Shy et al., 2007), but also activation of cAMP-response element binding protein 
(CREB) via mitogen-activated protein kinase (MAPK) pathway (Shy et al., 2007; Xing et 
al., 1996; Tu et al., 2007). It should be noted that CREB is a transcription factor and can 
promote the gene expression of AC (Lane-Ladd et al., 1997). Apart from the typical 
signaling from Gi/o protein, stimulation of the μ-opioid receptor is capable of regulating 
other multiplicity of transduction pathways such as activities of phospholipase C (Xie et 
al., 1999), PKC (Sanchez-Blazquez et al., 2010), Src kinase (Zhang et al., 2009), MAPK 
family and protein phosphatase (Gabra et al., 2007) in a variety of cells (Ortiz et al., 
1995; Kam et al., 2004). Each of these is suggested to participate in mediating multiple 
physiological actions of opioid drugs including nociception, reward, tolerance and 
dependence (Pellegrini-Giampietro et al., 1988; Xie et al., 1999; Moncada et al., 2003; 
Gabra et al., 2007; Komatsu et al., 2009; Zhang et al., 2010; Sanchez-Blazquez et al., 
2010; Rehni and Singh, 2011; Liu et al., 2011), implicating that there may be potential 
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interactions between these intracellular effectors. However, it is still unclear which of 
these play a dominant role and how they coordinate to form distinct mechanism(s) for 
specific opioid actions.  
 
1.4 Morphine-induced neuronal modulations: synaptic 
strength and organization        
Classically, stimulation of μ-receptors with opioids can directly reduce the 
excitability of neurons by inhibiting AC activity; suppressing voltage-gated Ca2+ channels 
to prevent Ca2+ influx and activating K+ channel to cause hyperpolarization as mentioned 
earlier (section 1.3.). The decreased neuronal excitability inhibits nerve impulse 
transmission and neurotransmitter release, thereby affecting the signal propagation in 
the entire neural circuit (Fig.1.1). Depending on the site, opioids regulate the release of 
excitatory or inhibitory neurotransmitters. Glutamate and substance P are examples of 
excitatory neurotransmitters. Primary afferent neurons of the DRG which express high 
density of the μ-opioid receptors (Delfs et al., 1994; Zastawny et al., 1994) are 
responsible for receiving and relaying pain signal. Pain generation is normally 
associated with excitation of primary afferent neurons, which in turn release glutamate 
and substance P in the dorsal horn of the spinal cord for forwarding the nociceptive 
information to the brain (Fig. 1.2). On the other hand, morphine acts on the μ-opioid 
receptors to deactivate the primary afferent neurons and inhibit the release of these two 
excitatory neurotransmitters at presynaptic terminals, so that it can produce analgesia 
(Fig. 1.2) (Piercey et al., 1979; Kondo et al., 2005). Another classical neural circuit 
mediated by morphine has been described in periaqueductal gray (PAG), VTA and 
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hippocampus where morphine reduces the presynaptic release of γ-aminobutyric acid     
(GABA, an inhibitory neurotransmitter). As a result, the activities of adjacent PAG 
neurons, dopaminergic and pyramidal neurons are enhanced through a disinhibitory 
mechanism (Johnson and North, 1992; Zieglgansberger et al., 1979; Vaughan and 
Christie, 1997) (Fig. 1.3). Aside from the presynaptic action, recent studies on primary 
hippocampal neurons have suggested that morphine likely has a direct postsynaptic 
effect in mediating activity of excitatory synapses. Chronic treatment of hippocampal 
cultures with morphine led to a reduction of the amplitude, frequency, rise time and 
decay time of miniature excitatory postsynaptic currents (mEPSCs) only in dendritic 
spines that contained postsynaptic μ-opioid receptors (Liao et al., 2005; Liao et al., 
2007). Collectively, these presynaptic and postsynaptic actions of morphine together 
with myriads of signaling transductions (described in section 1.3.3) cause alterations in 
synaptic strength (i.e. synaptic plasticity).  
 Changes in synaptic strength are often associated with changes in synaptic 
structure, such as size, density and shape of synapses, and they reciprocally affect each 
other for configuring a new synaptic connectivity. Therefore, it is not surprising that 
morphine and other opioid drugs have impact on synaptic organization. Mei et al (2009) 
demonstrated that the total length and branch number of dendrites as well as the density 
of spines were significantly reduced in pyramidal neurons of lateral secondary visual 
cortex of juvenile rats after prenatal morphine exposure, providing a potential 
mechanism by which infants of addicted mothers have deficits in brain development and 
psychological behaviors. Consistent observations occur in adult animals as well. 
Regardless of whether it is experimenter- or self-administration, chronic treatment of 
adult rats with morphine decreased density of spines in many brain areas, including 
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frontal cortex, sensory cortex and nucleus accumbens. Interestingly, the decreased 
spine density in hippocampus only occurred in rats self-administrated morphine 
(Robinson and Kolb, 1999; Robinson et al., 2002). Altogether, the ability of morphine to 
remodel synaptic strength and morphology contributes to neural modulations in specific 
neural circuits that may account for opioids’ physiological actions, especially addiction.  
 
1.5 AMPA receptors are involved in synaptic plasticity  
Synaptic plasticity results from not only changes in the amount of 
neurotransmitters released into a synapse, but also changes in the level of 
corresponding receptors on the synapse. It is well-known that this synaptic modification 
often involves two excitatory postsynaptic receptors, N-methyl-D-aspartate (NMDA) 
receptors and α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors 
(Kandel and O'Dell, 1992). NMDA receptors and AMPA receptors are two principle 
ionotropic glutamate receptors (GluRs) to mediate the excitatory transmission in the 
mammalian CNS. Accumulating evidence indicates a remarkable difference in synaptic 
expression on both receptors. NMDA receptors are statically localized at postsynaptic 
membranes, whereas AMPA receptors undergo a dynamic exchange among 
intracellular pools, synaptic membrane and extrasynaptic membranes in response to 
actual neuronal activities (Liao et al., 1995; Lissin et al., 1999; Borgdorff and Choquet, 
2002). Therefore, the number of surface-expressed AMPAR receptors at synapses in 
particular determines the strength of glutamatergic excitatory synapses (Liao et al., 
1995; Luscher et al., 1999). At resting membrane potential, AMPA receptors but not 
NMDA receptors can open upon glutamate binding due to a voltage-dependent Mg2+ 
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blockage in the pores of NMDA receptors. Hence, AMPA receptors primarily control the 
strength of excitatory synapses under normal conditions (Mayer et al., 1984; Isaac et al., 
1995) (Fig. 1.4A). Once depolarization is generated by sodium influx through AMPA 
receptors into postsynaptic cells, Mg2+ cations are expelled out into the extracellular 
space, and Na+ and Ca2+ cross NMDA receptors to the postsynaptic terminal (Fig. 1.4B). 
The entry of Ca2+  stimulates various protein kinases such as calcium/calmodulin-
dependent protein kinase (CaMKII) and PKC and finally evokes synaptic insertion of 
AMPA receptors, which results in a long-lasting strengthening of synapses, called long-
term potentiation (LTP) (Mayer et al., 1984; Pickard et al., 2001) (Fig. 1.4C). LTP, 
together with long-term depression (LTD, weakening of synapses), are well studied 
forms of synaptic plasticity (Bliss and Collingridge, 1993). Of note, LTD involves the 
removal of AMPA receptors from the postsynaptic sites (Shepherd and Huganir, 2007). 
 
AMPA receptors are tetramers made up of different combinations of four 
subunits: GluR1, GluR2, GluR3 and GluR4. Each subunit comprises ~ 900 amino acids 
with a molecular weight of about 105 kDa. Subunit composition varies depending on the 
brain region and developmental stage, but at adult hippocampus two major populations 
of receptors are heterotetrameric GluR1/GluR2 and GluR2/GluR3 (Craig et al., 1993; 
Wenthold et al., 1996; Shi et al., 2001). GluR4 expression is mainly restricted to the 
early development (Zhu et al., 2000). Each subunit has a large extracellular N-terminus 
and four transmembrane domains displaying substantial homology among different 
subunits. Conversely, their cytoplasmic C-termini diversify to be either long (e.g. GluR1 
and GluR4) or short (e.g. GluR2 and GluR3) (Kohler et al., 1994) that can determine 
their interactions with scaffolding proteins to regulate trafficking and stabilizing synaptic  
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AMPA receptors (Shi et al., 2001) (Fig. 1.5). Unlike NMDA receptors, the principal ions 
gated by AMPA receptors are Na+ and K+. The permeability of AMPA receptors to Ca2+ 
depends on the presence or absence of GluR2 subunits. The mRNA encoding for GluR2 
undergoes a post-transcriptional editing by which an uncharged glutamate (Q) (within 
the second transmembrane) in the pore region is altered to positively charged arginine 
(R), thereby causing energetically unfavorable condition for Ca2+ to pass through 
(Sommer et al., 1991). In adult mammalian brains, the vast majority of GluR2 subunits 
are Q/R edited, and thus the presence of GluR2 in AMPA receptors makes the channel 
impermeable to Ca2+. The prevention of Ca2+ entry into neurons is proposed as a 
mechanism against excitotoxicity (Kim et al., 2001). In contrast, if AMPA receptors lack 
GluR2 subunits, they become permeable to Ca2+. The Ca2+ influx is associated with high 
channel conductance, accelerated kinetics and inward rectification (Swanson et al., 
1997; Oh and Derkach, 2005). Therefore, the existence of GluR2 in AMPA receptors can 
control the receptor properties and so subsequent synaptic transmission (Derkach et al., 
2007).  
 
1.6 Molecular mechanisms for regulation of AMPA receptor 
trafficking and cellular distribution       
1.6.1 Interactions between intracellular C-termini of AMPA receptors and 
scaffolding proteins  
The C-terminal cytoplasmic tails of AMPA receptor subunits are diversified and 
can bind to a variety of regulatory proteins for mediating receptor assembly and 
  17 
 
 
 
 
  18 
trafficking (Borgdorff and Choquet, 2002). Numerous studies hence identify what 
proteins can bind to the regions and determine what specific roles the proteins play in 
the process. These interacting proteins basically can be divided into two categories: 
proteins that have PDZ domains and those that do not have.  
The PDZ domain is an about 90 amino acid motif and is also known as the GLGF 
repeat, based on the presence of a Gly-Leu-Gly-Phe sequence. Most PDZ-mediated 
interactions occur via the recognition of short peptide sequences, which are located on 
the C-terminal tails of the binding proteins (Songyang et al., 1997). SAP90/PSD95 is the 
first identified PDZ-domain containing protein at vertebrate CNS synapses (Cho et al., 
1992). Three additional isoforms, SAP97/hDlg, SAP102 and Chapsyn110/PSD93 were 
subsequently found (Garner and Kindler, 1996). This family of synapse-associated 
proteins (SAPs) is shown to preferentially express at the postsynaptic density of the 
glutamatergic synapses (Garner and Kindler, 1996). Currently, SAP97 is the exclusive 
PDZ protein known to interact directly with GluR1 and concentrates at synapses 
containing GluR1, but not necessarily GluR2 and GluR3 (Leonard et al., 1998; 
Valtschanoff et al., 2000), demonstrating a potential role for SAP97 in synaptic assembly 
of GluR1. Furthermore, a non-PDZ protein, actin binding protein 4.1 (4.1N), which is also 
enriched at synapses can form complexes with SAP97 and the homolog hDlg (Lin et al., 
1997; Walensky et al., 1999). Hence, a putative mechanism for synaptic insertion of 
AMPA receptors indicates that the formation of SAP97 and 4.1N complex at synapses 
may serve as a platform for anchoring AMPA receptors via a mechanism involving 
autophosphorylated CaMKII by NMDA receptors (Leonard et al., 1998; Shen et al., 
2000; Lisman and Zhabotinsky, 2001). During LTP induction, the transient Ca2+ entry 
through NMDA receptors leads to activation and persistent autophosphorylation of 
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CaMKII. The phosphorylated CaMKII then tightly bind to the NMDA receptors, where it 
may initiate a chain of protein-protein interactions including association with α-actinin 
and actin filaments. These actin filaments may provide a binding site for 4.1N that in turn 
forms a complex with SAP97. As 4.1N and SAP97 can interact with GluR1 subunits of 
AMPA receptors (Leonard et al., 1998; Walensky et al., 1999; Shen et al., 2000), the 
receptors anchor on this protein-complex platform at the synapses (Lisman and 
Zhabotinsky, 2001) (Fig. 1.6).    
 Despite of no direct interaction with AMPA receptors, PSD95 also affects their 
synaptic incorporation indirectly through a family of proteins called stargazin or 
transmembrane AMPA receptor regulatory proteins (TARPs). TARPs are recognized as 
key auxiliary subunits for AMPA receptors expressing on cell surface membrane, 
because several genetic studies have found that hippocampi of mice deficient in TARPs, 
especially TARPγ-8 isoform, had impairment in surface expression of AMPA receptors 
(Rouach et al., 2005). Importantly, another study demonstrated that TARPs could couple 
to AMPA receptors and PSD-95 at independent sites (Chen et al., 2000). This study also 
revealed that TARPs did not require PSD95 coupling to promote surface expression of 
AMPA receptors but relied on this interaction to cause clustering and retention of AMPA 
receptors at postsynaptic sites (Chen et al., 2000). In other words, TARPs may provide a 
link through which PSD-95 facilitates synaptic recruitment of AMPA receptors (Fig. 1.7).           
For GluR2 subunits, at least three PDZ-domain containing proteins are well-known to 
interact with their C-termini, including glutamate receptor interacting protein (GRIP), 
AMPA receptor binding protein (ABP) and protein interacting with C kinase 1 (PICK1) 
(Dong et al., 1997; Srivastava et al., 1998; Xia et al., 1999) (Fig. 1.7). These proteins are 
widely thought to mediate distinct steps in GluR2 trafficking. For example, GRIP and 
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 ABP serve as scaffolding proteins for anchoring GluR2 at postsynaptic sites (Dong et 
al., 1997). However, PKC or CaMKII-regulated interaction of PICK1 with GluR2 
promotes internalization of the receptor subunit, followed by a decrease in surface 
GluR2 but not GluR1 at hippocampal CA1 synapses (Fig. 1.7). Therefore, these results 
suggest a specificity of internalization mechanism for different subunits of AMPA 
receptors (Terashima et al., 2004).  
  
1.6.2 The role of AMPA receptor phosphorylation 
All four subunits of AMPA receptors have several identified phosphorylation sites 
on their intracellular C-termini, and this receptor modification is another contributing 
factor for mediating receptor trafficking, localization and so synaptic plasticity (Song and 
Huganir, 2002). GluR1 subunits have at least two phosphorylation sites. Among them, 
serine 845 and serine 831 are the most extensively studied and are thought to 
participate in NMDA-dependent LTP and LTD (Song and Huganir, 2002). Serine 845 is a 
substrate for protein kinase A (PKA), while serine 831 can be phosphorylated by PKC 
and CaMKII during LTP (Roche et al., 1996; Mammen et al., 1997). It seems that 
phosphorylation of serine 845 by PKA facilitates GluR1 targeting at extrasynaptic sites 
only, but is insufficient to deliver AMPA receptors at synapses (Oh et al., 2006). 
Therefore, other signaling events such as phosphorylation of serine 831 and other 
residues on GluR1, as well as coupling to scaffolding proteins may be required (Hayashi 
et al., 2000; Esteban et al., 2003). On the other hand, induction of LTD involves protein 
phosphatase such as PP1/2A to dephosphorylate these two serine residues, which in 
  23 
turn promotes internalization of cell surface GluR1 (Lee et al., 2003; Lee et al., 2004; 
Holman et al., 2007).  
GluR2 have two common phosphorylation sites near its C-terminus, serine 880 
and tyrosine 876 which are substrates for PKC and Src family tyrosine kinases, 
respectively (Seidenman et al., 2003; Hayashi and Huganir, 2004). Increased 
phosphorylation of both sites are found to be a critical step in the induction of cerebellar 
and hippocampal LTD (Seidenman et al., 2003; Chung et al., 2003; Hayashi and 
Huganir, 2004). In fact, phosphorylation of serine 880 and tyrosine 876 appears to 
destabilize the interaction of GluR2 with GRIP/ABP and allows recruitment of PICK1 to 
AMPARs, therefore facilitating the endocytosis of GluR2 (Seidenman et al., 2003; 
Hayashi and Huganir, 2004).  
Taken together, there are at least two essential events for regulating AMPA 
receptor trafficking and localization, including interactions of receptors with synaptic 
scaffolding proteins and AMPA receptor phosphorylation. In fact, recent studies have 
proposed more complex scenario that involved some adhesion molecules and secreted 
factors binding to the extracellular domains of AMPA receptors (Passafaro et al., 2003; 
Saglietti et al., 2007).  
 
1.7 Implications of AMPA receptor trafficking  
A dynamic change in the level of synaptic AMPA receptors contributes to the 
generation of long-lasting synaptic plasticity – LTP and LTD, which may encode new 
information stored in the brain and thus modification of behaviors, especially learning 
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and memory. Therefore, regulation of AMPA receptor trafficking during synaptic plasticity 
is proposed to be one of the cellular mechanisms underlying the cognitive function. This 
notion is supported by findings of several elegant studies on mice with deficiency of 
GluR1 (and so GluR2/3 as predominant AMPA receptors) that was generated by 
Zamanillo and coworkers (Zamanillo et al., 1999). In comparison with wild type animals, 
the mutant mice had normal AMPA receptor- and NMDA receptor-mediated basal 
synaptic transmission, but exhibited impaired LTP (Andrasfalvy et al., 2003), revealing 
that synaptic delivery of GluR1-containing AMPA receptors is crucial for the induction of 
LTP. More importantly, the GluR1-lacking mice displayed deficit in hippocampus-
dependent spatial working memory (Reisel et al., 2002; Schmitt et al., 2003) and one-
trial spatial memory (Sanderson et al., 2007). Therefore, these results suggest that 
AMPA receptor trafficking was required for hippocampus-dependent learning and 
memory. As mentioned in section 1.6.2, trafficking of AMPA receptors depends on the 
receptors’ phosphorylation status and hence mutation on these phosphorylation sites is 
also expected to affect synaptic plasticity and likely certain cognitive behaviors. For 
instance, NMDAR-dependent LTD was absent in transgenic mice lacking both PKA and 
CaMKII phosphorylation sites on GluR1 (S845A and S831A), which had normal Morris 
water maze learning but was impaired in rapid acquisition of new platform location (Lee 
et al., 2003) as well as incentive learning for food reinforcement (Crombag et al., 2008). 
These findings provide evidence that a particular form of LTD requiring GluR1 
dephosphorylation underlies specific types of learning and memory.   
 
1.8 Research goals 
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 Opiate drugs including morphine are the most powerful analgesics known, but 
their clinical applications for the treatment of chronic pain are impeded by the 
development of drug addiction. Drug addiction indeed is related to experience-based 
behaviors such as the pursuit of rewards and cues linking drugs. Hence, it is considered 
a pathological form of learning and memory (Kelley, 2004; Hyman, 2005), which involves 
reorganization and/or strengthening of synaptic connections in specific neural circuits. 
Consistently, previous reports demonstrated that chronic morphine exposure not only 
reduces dendritic branching and spine density in different brain regions, but also alters 
both basic synaptic transmission and synaptic plasticity in hippocampus (Robinson and 
Kolb, 1999; Liao et al., 2005; Pu et al., 2002). Therefore, study on how chronic morphine 
treatment induces such long-lasting neural modulations is required to advance our 
understanding of addiction development, but the detailed molecular mechanism still 
remains unclear. As described earlier (section 1.5), dynamic trafficking of AMPA 
receptors plays a crucial role in the expression of synaptic plasticity (Malinow and 
Malenka, 2002) and also contributes to mediating spine growth and stability (Kopec et 
al., 2007). Importantly, immunostaining studies in hippocampal and cortical neurons 
revealed μ-opioid receptors forming clusters in spines that are co-localized with AMPA 
receptors (Liao et al., 2005). Thus, we hypothesize that morphine treatment can alter the 
dynamic localization of AMPA receptors, which is a key factor for the drug-induced 
neuronal modulations. In this dissertation research, the main goal is to investigate the 
molecular mechanisms underlying morphine-induced neuronal modulations or synaptic 
impairments, which can be associated with opiate addiction. To achieve this goal, we 
have three specific objectives: 
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1) To examine the dynamic trafficking of AMPA receptors following morphine 
application in cultured neurons of hippocampus, a brain area related to addiction; 
2) To delineate the signaling pathways that govern morphine-regulated AMPA 
receptor trafficking, and; 
3) To investigate the physiological role of the regulated AMPA receptor trafficking in 
vivo, especially morphine’s reinforcing and seeking behavior.  
 
In the classic model of addiction, the dopaminergic system, including VTA and 
nucleus accumbens, is a well-known reward circuitry important for addiction (Di Chiara 
and Imperato, 1988). However, the hippocampus, a vital brain region for contextual 
learning and memory consolidation, has recently been found to regulate the rewarding 
effects of abused drug (Fan et al., 1999; Vorel et al., 2001). Furthermore, hippocampal 
glutamatergic neurons directly project to the nucleus accumbens (Floresco et al., 2001) 
and can modulate many activities of dopaminergic neurons in the VTA (Legault et al., 
2000). Hence, the hippocampus is believed to play an important role in drug addiction, 
and the exploration of hippocampal neuromodulation induced by addictive drugs will be 
critical in our understanding of the mechanisms for addiction (Koob and Volkow, 2010; 
Morón and Green, 2010). In this study, we therefore used cultured hippocampal neurons 
as a cellular model. 
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MATERIALS AND METHODS 
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2.1 Materials 
2.1.1 cDNA and Animals 
 For cDNA, a plasmid encoding superecliptic pHluorin in pCI-neo was kindly 
provided by Dr. Gero Miesenböck (University of Oxford, UK). For animals, a line of 
heterozygous mice harboring a mutation on GluR1-S845 on a C57BL/6J genetic 
background was a generous gift from Dr. Richard L. Huganir (Johns Hopkins School of 
Medicine, Baltimore, MD, US) and pregnant Sprague-Dawley rats were purchased from 
Harlan Laboratories.  
 
2.2.2 Drugs, Reagents and Softwares 
 Drugs and reagents purchased from Sigma-Aldrich (St. Louis, MO) include: D(-)-
2-amino-5-phosphonovaleric acid (D-APV), dibutyryl cyclic-AMP (dbcAMP), tetrodotoxin 
(TTX), 5’Fluoro-2’-deoxy-uridine (FUDR), uridine, poly-L-lysine, L-cystine, bovine serum 
albumin (BSA), ovornucoid, glutathione,  iodoacetamide, regulatory subunit of type II 
cAMP-dependent protein kinase, Protein kinase A (PKA) catalytic subunit, protein A-
Sepharose, l-cysteine, Earle’s Balanced Salt Solution (EBSS), deoxyribonuclease 
(DNase). Other reagents are obtained from different manufacturers such as streptavidin-
agarose beads and sulfo-NHS-SS-biotin from Pierce (Rockford, IL), papain from 
Worthington (Lakewood, NJ), FK506 from Calbiochem (La Jolla, CA) and Effentene 
transfection reagent (Qiagen, CA). Sep-Pak C18 chromatography column was from 
Millipore (Billerica, MA). Life technologies (Gaithersburg, MD) provided various media 
and reagents for cell cultures including NeuroBasal media, Minimum Essential Media 
(MEM), heat-inactivated fetal bovine serum, heat-inactivated horse serum, sodium 
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pyruvate, penicillin, streptomycin, L-glutamine and B27 supplement. Furthermore, 
antibodies against GluR1 and phospho-GluR1-S845 were from Chemicon (Temecula, 
CA), while anti-PSD-95 antibody was purchased from Santa Cruz Biotechnology (Santa 
Cruz, CA). For software programs, ImageJ, IPLab4 and ANY-mazeTM Video Tracking 
system were available from National Institutes of Health (Bethesda, MD), BD 
Biosciences (San Jose, CA) and Stoelting (Wood Dale, IL), respectively.  
 
2.2 Construction of recombinant receptors and site directed 
mutagenesis 
 The coding sequence of superecliptic pHluorin was amplified by PCR 
(QuikChange protocol; Stratagene, La Jolla, CA) and inserted into the N-terminus of rat 
GluR1 after a signal peptide in pRK5 vector. The tagging position with pHluorin in GluR1 
was exactly the same as that with enhanced GFP, which has been shown to have no 
effect on the receptor function (Shi et al., 1999; Lin e al., 2004). A point mutation of 
GluR1 at Ser845 was generated by site-directed mutagenesis using PCR according to the 
guidelines in QuikChange® manual. The pairs of mutagenic primers are indicated as 
below. 
For mutating GluR1 at Ser845 to alanine: 
5’-CCCTCCCCCGGAACGCTGGGGCAGGAGCCAGCGG-3’ (sense)  
5’-CCGCTGGCTCCTGCCCCAGCGTTCCGGGGGAGGG-3’ (anti-sense) 
For mutating GluR1 at Ser845 to aspartic acid:  
  30 
5’-CCCTCCCCCGGAACGATGGGGCAGGAGCCAGCGG-3’ (sense) 
5’-CCGCTGGCTCCTGCCCCATCGTTCCGGGGGAGGG-3’ (anti-sense)  
 
2.3 Cell cultures 
2.3.1 Primary Hippocampal Culture 
 Dissociated neuronal cultures were prepared from hippocampi of Sprague-
Dawley rats or C57BL/6J mice at postnatal days 1 and 2 (Liao et al., 1999). In brief, 
isolated hippocampi were incubated in Digestion Solution [0.5 mM EDTA, 15 mg papain 
and 4 mg l-cysteine in Earle’s Balanced Salt Solution (EBSS)] for 30 minutes at 37 °C, 
swirling occasionally. The digestion solution was removed and Inhibition Solution (1 
mg/ml BSA, 1 mg/ml ovornucoid, 0.001% DNase in EBSS) was added. The brain tissue 
was triturated with a 10-ml pipette until most chunks disappeared. The chunks of 
undissociated tissue were allowed to settle for 3 minutes. The supernantant was then 
carefully collected and centrifuged at 2000 rpm for 10 minutes at 4 °C. The cell pellet 
was resuspended in Plating Media (10% heat-inactivated fetal bovine serum, 5% heat-
inactivated horse serum, 200 mM L-cystine, 10 mM sodium pyruvate, 50 units/ml 
penicillin, 50 μg/ml streptomycin, L-glutamine). For live-cell imaging experiments, 
neurons were plated at a density of 1 × 106 cells per dish onto a 35-mm glass-bottom 
petri dish coated with poly-L-lysine (thickness of glass coverslip = 0.08 mm; Lin et al., 
2004). For all other biochemical studies, 3 × 106 cells were plated onto a poly-L-lysine-
treated 60-mm petri dish. After removing the plating medium,  hippocampal cultures 
were maintained in Neuron Feeding Media [NFM; 25% NeuroBasal media, 2%  heat-
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inactivated horse serum, 2% B-27, 10 mM sodium pyruvate, 0.016 mg/ml 5’Fluoro-2’-
deoxy-uridine (FUDR), 0.032 mg/ml uridine, penicillin, streptomycin, L-glutamine in 
Minimum Essential Media (MEM)]  and were kept at 37 °C in humidified air with 5% CO2 
(Ghosh and Greenberg, 1995; Liao et al., 1999). One week after plating, and every week 
thereafter, the cultures were fed with one-fourth volume of conditioned media from glial 
cells (section 2.3.2 Glial Culture). From the day of plating, cultured neurons were 
counted as DIV1 (day 1 in vitro). Neurons at DIV18-24 were used for imaging and 
biochemical experiments. 
 
2.3.2 Glial Culture  
 To prepare a culture of glial cells, a total of 4 x 106 dissociated hippocampal cells 
(as described in section 2.3.1 Primary Hippocampal Culture) was plated onto a 150-mm 
culture plate. Glial Feeding medium (5% heat-inactivated horse serum, 10 mM sodium 
pyruvate, 50 units/ml penicillin, 50 μg/ml streptomycin, L-glutamine in MEM) was used 
for maintaining glial cell growth. In order to obtain glial conditioning media, the glial 
feeding medium was changed out for fresh NFM one week after plating. Two days later, 
the conditioned NFM from the glial culture was collected, followed by addition of 1X 
FUDR. The entire conditioned medium was eventually sterile-filtered (0.2 μm). 
 
2.3.3 Clonal Cell Culture 
 For clonal cell line, Human Embryonal Kidney 293 (HEK293) cells were cultured 
in MEM, supplemented with 10% fetal bovine serum, 50 units/ml penicillin and 50 μg/ml 
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streptomycin at 37 °C in humidified air with 5% CO2. Cells were fed every 3-4 days with 
fresh media until about 90% confluent in 100 mm tissue culture dishes. After removing 
the medium and washing with 5 ml 1X PBS, HEK293 cells were rinsed with 1 ml of 1X 
trypsin-EDTA solution for 3 minutes and resuspended in 9 ml of fresh medium. 1 ml of 
cell suspension was dispensed onto one dish for subculturing or diluted at a density of 4 
x 105 cells/ml and seeded onto 6-well plates for transfection.  
 
2.4 Transfection 
 Primary hippocampal neurons at DIV5-9 were transfected with various plasmids 
by standard calcium phosphate co-precipitation method (Ghosh and Greenberg, 1995). 
The Neuron Feeding Medium from primary cultures was collected, and about 300 μl glial 
conditional medium (section 2.3.2 Glial Culture) containing D(-)-2-amino-5-
phosphonovaleric acid (D-APV) was added for covering each glass coverslip, which cells 
grown on. To prepare a precipitate for one coverslip, sterile H2O, 1.5 μl CaCl2 and 6 μg 
plasmid DNA in a final volume of 30 μl were mixed together in order. The CaCl2/DNA 
dropwise was added to 15 μl of 2X HEPES-buffered saline (274 mM NaCl, 9.5 mM KCl, 
0.38 mM Na2HPO4.7H2O, 15 mM D-glucose and 42 mM HEPES in H2O, pH 7.1-7.15 )  
while swirling. After incubation of the precipitate solution for 30 minutes at room 
temperature, the entire solution was added onto the center of the coverslip. Then, the 
hippocampal culture was incubated for 5 h at 37 °C in a CO2 incubator. The transfection 
medium was aspirated and 2 ml of the original medium supplemented with the glial 
conditional medium was added.  To transfect HEK293 cells, Effectene transfection was 
conducted according to the manufacturer’s instructions.  
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2.5 Live-cell confocal imaging and data analysis 
 Images were acquired by a 63× oil immersion objective of a Leica DMIRE2 
fluorescence microscope, connected to a BD CARVII TM confocal imager and a 
Hamamatsu EM CCD camera (Joiner et al., 2009). To maintain neuronal viability during 
image capturing, transfected hippocampal cultures were placed in a temperature-
controlled chamber installed on the microscope (heated at 37°C) with continuous 5% 
CO2 infusion (Leica Microsystems). Cells were then immediately returned to a humidified 
5% CO2 incubator at 37°C for prolonged drug treatment. All transfected cells, except 
those with abnormal morphologies, were randomly photographed. The X-Y coordinates 
of individual neurons on the stage fitted with X-Y translation were recorded by the 
IPLab4 software program, so that the same neuron could be located and imaged at 
different time points during the drug treatment.  
All confocal images were taken as stacks (≤ 25 z-planes) at 0.4 μm intervals and 
then merged into one single image before further analysis with IPLab4 software as 
described (Joiner et al., 2009). The averaged pHluorin-GluR1 fluorescence of the cells 
was based on the quantification of the pHluorin-GluR1 intensity of each individual 
neuron in the field of view. To obtain this data, total area of the cell from the entire image 
was selected by an “autosegmentation” function in the IPLab4 program. 
In the case of measuring fluorescence intensities (including pHluorin-GluR1 and 
DsRed) on specific regions such as spines and dendrites, the Region of Interest (ROI) 
was manually highlighted with “Segment Tools”. All fluorescence measurements 
represented raw data with background subtractions of the averaged blank field 
intensities. Dendritic spine was defined as a dendritic protrusion containing a rounded 
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head (Murai et al., 2003; Liao et al., 2005). Spine density was calculated by the number 
of spines normalized against the dendritic length (100 μm) in DsRed images.  
 
2.6 Western blotting analysis 
After drug treatments, cells were washed one time with Phosphate buffered 
saline (PBS) at 4°C, then immediately solubilized in extraction buffer [50 mM Tris, pH 
7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.5% sodium deoxycholate, 30 mM 
NaF, 1 mM sodium orthovanadate, 1 mM dithiothreitol (DTT) and Complete protease 
inhibitor mixture (Roche, Basel, Switzerland)]. Supernatants of the lysates were 
collected after centrifugation at 13,000 × g for 5 min. A protein concentration in each 
sample was determined by a BCA assay (Pierce, IL) according to instructions supplied. 
About 0.8-1 mg proteins of each sample were used for either immunoprecipitation or 
biotinylation as described in section 2.7 and 2.8, respectively. The samples were then 
subjected to 10% Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-
PAGE) to separate proteins depending on their charge and molecular weight. After 
electrophoresis, electroblotting was performed for transferring the separated proteins 
onto a polyvinylidene difluoride membrane. In order to prevent non-specific background 
binding of antibodies to the membrane, it was firstly agitated in a blocking solution for at 
least 1 h at room temperature. The blocking solution is made of 5% w/v nonfat dry milk 
in Tris Buffered Saline with Tween-20 (TBST; 50 mM Tris-HCl, pH 7.4, 150 mM NaCl and 
0.1% Tween 20). About 15 ml of the blocking solution containing a primary antibody, 
such as antiserum against GluR1 was incubated with the blocked membrane at 4 °C 
overnight. Later, the membrane was washed twice with TBST for 15 minutes each, 
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followed by incubation with the blocking solution containing alkaline phosphatase-
conjugated secondary antibody for at least 1 h at room temperature. TBST was used 
again for washing the membrane three times for 15 minutes each. Then, the immunoblot 
was incubated with a ECF substrate (GE Healthcare, Buckinghamshire, UK) for 6 
minutes to yield a highly fluorescent product, which can be detected by STORM 860 
Analysers. The fluorescence intensity of each protein band was quantified using ImageJ.    
 
2.7 Immunoprecipitation  
After drug treatments, cells in 60-mm dishes were then lysed in 1 ml extraction 
buffer (as shown in 2.6 Western blotting analysis), followed by a centrifugation at 13,000 
× g for 5 min. The pellets were discarded, whereas the supernatants of cell lysates were 
collected for BCA assay. 50 μl aliquot of the cell extracts was saved prior to 
immunoprecipitation for determining total level of AMPA receptor. About 0.8-1 mg total 
proteins were immunoprecipitated with 2 μg anti-GluR1 antibody at 4°C overnight under 
agitation. After a 3 h-incubation with protein A-Sepharose (50-60 μl), the pull-down 
complexes were washed three times with the extraction buffer without sodium 
deoxycholate. The GluR1 protein complexes finally were eluted by 2× Laemmli buffer, 
followed by SDS-PAGE and Western blotting analysis. The amounts of proteins in the 
receptor complexes were detected with antibodies against phospho-GluR1-S845, GluR1 
and PSD-95.  
 
2.8 Biotinylation 
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To label all surface proteins, after washing with ice-cold PBS/Ca2+/Mg2+ (10 mM 
phosphate buffer, 2.7 mM KCl, 137 mM NaCl, 1 mM CaCl2, 0.5 mM MgCl2, pH 7.4), 3 
week-old hippocampal neurons in 60-mm dishes were incubated with sulfo-NHS-SS-
biotin (300 μg/ml) for 30 min at 4°C to biotinylate cell surface proteins as described 
previously (Mammen et al., 1997; Lin et al., 2000). The unbound biotin was washed 
away by PBS/Ca2+/Mg2+ containing 0.1% BSA at 4ºC. The biotinylated cells were then 
incubated with the original growth media with or without 10 μM morphine (in the 
presence or absence of inhibitors if necessary) and returned to the 5% CO2 incubator at 
37°C for various time periods for receptor internalization. Receptor trafficking was 
stopped by rapidly cooling the cells at 4°C. Biotinylated proteins remaining on the cell 
surface were stripped by glutathione (150 mM glutathione, 150 mM NaCl, pH 8.75), but 
internalized receptors were protected and would still contain biotin. Subsequently, 50 mM 
iodoacetamide in PBS/Ca2+/Mg2+ was used to neutralize glutathione. Cells were then 
immediately solubilized in the extraction buffer (as shown in section 2.6 Western Blotting 
Analysis) lacking DTT. After centrifugation at 13,000 × g for 5 min, 50 μl supernatants 
were aliquoted for determining total amount of AMPA receptors in each sample, while 
about 0.8-1 mg cell extracts were agitated with streptavidin-agarose beads at 4°C 
overnight. Lastly, the biotinylated receptors in the pull-down complexes, which should 
represent internalized receptors, were eluted by 2× Laemmli buffer and resolved by 
SDS-PAGE. Antibodies against GluR1 and GluR2 were used to detect internalized 
AMPA receptors in the pull-down complexes and total receptor expressions in cell 
extracts.  
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2.9 In vitro phosphatase assay 
To measure phosphatase activity of calcineurin, 32P-labeled RII peptide substrate 
corresponding to 19 residues in the regulatory subunit of type II cAMP-dependent 
protein kinase or Protein Kinase A (PKA) was prepared as described (Fruman et al., 
1996). The serine phosphorylation of RII peptide substrate with [γ-32P]ATP was carried 
out by a PKA catalytic subunit. The kinase reaction contained the following 
concentrations: 500 μl of 2X Buffer A (40 mM MES buffer, pH 6.5, 4 mM MgCl2, 0.1 mM 
CaCl2, 0.4 mM EDTA, 0.8 mM EGTA, 1 mM DTT, 0.1 mg/ml BSA), 6 μl 50 mM ATP, 60 
μCi [γ-32P]ATP and 45 μl 3.3 mM RII peptide in a final volume of 900 μl. The 
phosphorylation of the peptides was initiated by the addition of 100 μl of PKA catalytic 
subunit with 250 units of activity at 30 °C for 1h. Then the labeled peptides and 
unincorporated ATP were separated by Sep-Pak C18 chromatography column. The 
column was firstly equilibrated by using a syringe to apply 3 ml of 30% acetonitrile in 
0.1% trifluoroacetic acid (TFA), followed by 5 ml of 0.1% TFA. After loading the entire 
kinase reaction to the column, the column was washed with 75 ml 0.1% TFA to remove 
the free ATP. Lastly, the radioactive peptides were eluted with 2 ml of 50% acetonitrile in 
0.1% TFA, and subsequently lyophilized and resuspended in 1 ml buffer B (50 mM Tris, 
pH 7.5, 100 mM NaCl, 0.5 mM DTT, 100 mg/ml BSA) to obtain an approximate 
concentration of 150 μM.   
After drug treatments, hippocampal neurons were lysed in hypotonic lysis buffer 
(50 mM Tris, pH 7.5; 1 mM EDTA; 0.1 mM EGTA; 0.5 mM DTT; 50 μg/ml PMSF; 10 μg/ml 
leupeptin and 10 μg/ml aprotinin). 6-8 μg of cell extracts were used for the phosphatase 
assay. Okadaic acid (OA) was added to the assay buffer (50 mM Tris, pH 7.5, 100 mM 
  38 
NaCl, 0.5 mM DTT, 100 μg/ml BSA, 0.1 mM CaCl2) in all experiments. Since OA can 
inhibit the activities of Ca2+-independent phosphatases including phosphatase 1 and 2A 
by more than 90%, but has no significant effect on calcineurin, calcineurin activity can be 
measured clearly under the assay condition containing OA (Fruman et al., 1996). 
Reaction mixtures for the phosphatase assay contained 20 μl of cell lysates, 20 μl of 
assay buffer, 100 nM OA and 20 μl of 15μM 32P-labeled RII peptide substrate. The 
mixtures were incubated at 30 °C for 10 min. Then, the reactions were terminated by 
adding 20 μl 50% trichloroacetic acid and 80 μl BSA (6 mg/ml). The samples were 
incubated on ice for 10 min, followed by centrifuging at 13,000 × g for further 10 min at 4 
°C. The amount of 32Pi released from RII peptide in the supernatant was measured by 
liquid scintillation. Blank samples containing only assay buffer were used. To determine 
the specific activity of the substrate, cpm in 20 μl of 15 μM substrate was measured. Net 
cpm for samples was calculated by substracting cpm measured in the blanks. The 
amount of 32Pi released (pmol) in each sample was calculated by dividing the net cpm for 
the sample by the specific activity of the substrate. Final phosphatase activity was 
expressed as percentage of the control without drug treatment.  
 
2.10 Animal behavioral studies 
2.10.1 Mouse Line 
 Wild type and GluR1-S845A homozygous mice on a C57BL/6 genetic 
background are generated through mating of heterozygous mutant mice. All animals 
were housed in a group of four per cage and maintained on a 12-h day/night light cycle 
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in animal facilities, which are accredited by the Institutional Animal Care and Use 
Committees (IACUC) of the University of Minnesota. Food and water were present ad 
libitum. For all behavorial studies, 10- to 14-week-old male mice of both wild types and 
homozygous mutants were used and each mouse was utilized only once for each 
experiment. Mice were acclimatized to the laboratory environment for one week before 
starting the study. During this period mice were handled and weighed. If necessary, they 
were even habituated to the drug administration procedure by receiving at least two 
subcutaneous (s.c.) injections of saline. All protocols were approved by the IACUC by 
which all possible measures were conducted to minimize the number of mice used and 
suffering of animals.  
 
2.10.2 Conditioned Place Preference (CPP) and locomotion 
 An experimental apparatus for CPP procedure is a three-compartment polyvinyl 
chloride box (Fig. 2.1). Two large side compartments provide different visual and tactile 
cues, such as black dotted or gray striped wall and smooth or rough floors respectively, 
and they are connected by a center transparent chamber. Removable guillotine doors 
are used to partition them. The CPP procedure consisted of three phases: i) habituation 
and preconditioning test, ii) conditioning as well as iii) CPP test. All experiments were 
conducted during the dark phase in dim light environment with a continuous masking 
noise. Moreover, animals’ location and locomotion in the apparatus were tracked and 
measured by using ANY-mazeTM Video Tracking system and conventional cameras. The 
procedure began with habituation for three days. Each mouse was placed separately  
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into the apparatus without any guillotine door for 15 minutes, so that they could explore 
the entire apparatus freely. On day 3, a preconditioning test was performed, in which the 
time spent in each compartment was recorded to determine any innate preference for 
either of the two large compartments. Animals showing a strong preference to any 
chamber (>60% of total time) were discarded, while others were grouped randomly: 
saline and morphine. The conditioning phase comprised two sessions per day (i.e. 
morning and afternoon session) for two to four consecutive days. All mice were injected 
with saline (0.9% NaCl, 1 ml/kg, s.c.) in the morning session and immediately confined 
to the assigned chambers for 40 minutes with using the guillotine doors. The ANY-
mazeTM Video Tracking system was used to measure their basal locomotor activity. The 
afternoon session began after at least 4 h, in which they were administrated with either 
saline or morphine (5 mg/kg or 10 mg/kg, s.c.) right before confinement to the alternative 
chambers. Similarly, their locmotor activity in response to morphine injection was 
determined as well. On the day of CPP test, the guillotine doors between compartments 
were removed and mice in a drug-free state were given free access to the whole 
apparatus for 15 minutes. The time spent in each chamber was recorded again. The 
CPP score (in sec.) was defined as the time spent in the morphine-paired chamber 
during CPP test minus that spent in the preconditioning test. If the score was higher than 
60 seconds, animals were recognized to have a preference for the morphine-paired 
chambers and so they were subjected to the subsequent extinction tests. Extinction test 
was the same as the CPP test (i.e. 15 minutes per session) and the test score was 
calculated by the time spent in the morphine-paired chamber during the extinction test 
minus that spent in the preconditioning test. Furthermore, it was carried out every two 
days until the drug preference response was extinct (i.e. test score <60 seconds) for 
three consecutive sessions. 
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2.10.3 Morris Water Maze 
Morris water maze was used for testing hippocampus-dependent spatial memory 
of mice and performed during the day phase of the light cycle with a circular swimming 
tank (120 cm in diameter, Fig. 2). ANY-mazeTM Video Tracking system was employed 
again to measure mice activity and position. The swimming tank was filled with opaque 
water and surrounded by white curtains that had simple distinct signs for providing 
spatial cues. One day before training, each mouse was habituated to the water tank 
once for 1 minute. The training involved a hidden platform paradigm, by which an 
escape platform (with 11 cm diameter) was placed 0.5 to 1 cm beneath the water 
surface in the center of a quadrant of the tank. Mice received four trials of training with 1-
min interval per day for six consecutive days. In each trial, they were placed into the tank 
randomly from four different designated start points and allowed to navigate for up to 60 
seconds until they landed on the platform. If mice failed to find the platform within 60 
seconds, they were manually guided to the position. The time each mouse spent to find 
the platform was scored as escape latency, and the score on each trial was averaged for 
a single day.  
 
2.11 Statistics 
All data are expressed as mean ± s.e.m. of the indicated number of experiments. 
Statistical significance was determined using t-test for a comparison between two groups 
and one-way or two-way ANOVA for a comparison between multiple groups (SPSS 13.0, 
Chicago, IL); a value of p < 0.05 was considered statistically significant.  
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3.1 The effect of morphine on AMPA receptor trafficking 
3.1.1 Expression of pHluorin-GluR1 can track dynamic location of AMPA 
receptors 
Prolonged treatment with morphine not only induced collapse of dendritic spines in vivo 
and in vitro, but also diminished frequency and amplitude of mEPSCs at hippocampal 
neurons, indicating a reduction of the postsynaptic AMPA receptors (Robinson et al., 
2002; Liao et al., 2005). However, no study has shown the temporal dynamics of AMPA 
receptor trafficking in response to morphine. To do this, we will use the latest approach 
that employs pH-sensitive GFP (super-ecliptic pHluorin) to visualize surface-expressed 
AMPA receptors at individual synapse in real time, due to its character of a reversible 
excitation ratio changes between pH 7.5 and 5.5 (Ashby et al., 2004). The pHluorin was 
introduced into the extracellular N-terminus of GluR1 (pHluorin-GluR1) (Fig. 3.1A), a 
subunit of AMPA receptors widely expressed in adult hippocampal neurons (Wenthold et 
al., 1996). The experimental principle is that pHluorin faced to the extracellular 
environment (about pH 7.4) can display a bright fluorescence, if pHluorin-GluRl locates 
at cellular surface. However, if the recombinant receptor undergoes internalization, 
pHluorin becomes stop to fluoresce because of exposing to the acidic lumens of 
endocytic and secretory vesicles (about pH 5.6) (Fig. 3.1B). To ensure the validity of the 
recombinant receptors, HEK293 cells were firstly transfected with either empty vector 
(Mock) or a plasmid encoding pHluorin-GluR1. Cell lysates then were immunoblotted 
with antibodies against GluR1 and green fluorescent protein (GFP) (Fig. 3.2A). Both 
antibodies could recognize a protein band with about 130 kDa in cells transfected with 
pHluorin-GluR1 but not control vector, and the molecular weight was corresponding to  
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the size of the recombinant receptor. This result so confirmed intact receptors to be 
expressed (Fig. 3.2A). The membranes were re-probed with an anti-F-actin antibody to 
show equal protein loading in each sample (Fig. 3.2A).   
To observe the distribution pattern of the recombinant AMPA receptor on 
neuronal cells, rat hippocampal cultures at DIV5-DIV9 were transfected with the plasmid 
of pHluorin-GluR1 by calcium phosphate co-precipitation method (Ghosh and 
Greenberg, 1995; section 2.4). At DIV18-24, images of transfected neurons were taken 
by a live-imaging system. Figure 3.2B (i) showed confocal fluorescence images on live 
neurons in pH 7.4 buffer that pHluorin-GluR1 effectively expressed in cells where they 
clustered in a punctate pattern on dendritic spines. We next determined whether the 
fluorescence came from the surface-expressed receptors. Thus cells were incubated in 
pH 6.0 buffer to quench the extracellular fluorescence (Fig. 3.2B, ii). The low pH buffer 
dramatically reduced dendritic fluorescence and completely removed that of spines (Fig. 
3.2B, ii), indicating that most of the fluorescence was attributable to the surface-
expressed receptors. Importantly, this reduced fluorescent signals could be reversed by 
replacement with pH 7.4 buffer again (Fig. 3.2B, iii), validating the pH sensitivity of 
pHluorin.  
 
3.1.2 Morphine elicited loss of surface-expressed GluR1 subunits 
To measure the dynamics of morphine-regulated AMPA receptor trafficking, cultured 
hippocampal neurons were contransfected with plasmids encoding pHluorin-GluR1 and 
DsRed (a soluble red fluorescence protein), which were used to visualize surface- 
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expressed AMPA receptors and to label dendritic spines, respectively. About two weeks 
after transfection (DIV18-24), same-labeled neurons were imaged before and 
after 10 μM morphine exposure at various time points (3h, 1d and 3d) (Fig. 3.3). Upon 
morphine exposure, a gradual decrease in fluorescence signal of the pHluorin-GluR1 
was observed (Fig. 3.3A). The average fluorescence of pHluorin-GluR1 from the entire 
image of morphine-treated neurons significantly decreased by 12.8% for 3 h, 21.6% for 1 
d, and 33.9% for 3 d after the drug application (relative to before morphine treatment) 
(Fig. 3.3B, top), implicating a loss of surface-expressed GluR1 by morphine. In contrast, 
the fluorescence intensity of pHluorin-GluR1 in untreated neurons remained constant or 
even slightly increased during the 3 d of observation, indicating that the decrease in 
green fluorescence by morphine was not due to photobleaching effect (Fig. 3.3A, B). 
Also, no significant change in overall protein expression of AMPA receptors was 
observed during drug treatment (Fig. 3.4A). Interestingly, quantitative analysis on 
individual spines and the adjacent dendrites in Figure 3.3B (middle and bottom) showed 
that treatment with morphine for 3 h clearly diminished the surface fluorescence of 
pHluorin-GluR1 on spines but not at dendritic shafts. Therefore, the loss of synaptic 
GluR1 by morphine should occur before the loss of extra-synaptic GluR1. Consistent 
with our previous studies (Liao et al., 2005), the density of DsRed-labeled spines was 
substantially reduced after 1 and 3 d of morphine treatment (before, 63.4±4.47 
spines/100 μm; 1 d, 43.3±4.02 spines/100 μm; 3 d, 37.2±3.28 spines/100 μm) (Fig. 3.5). 
These findings provide direct live imaging evidence that chronic treatment with morphine 
results in two distinct processes, including the loss of surface-expressed AMPA 
receptors and the loss of spines.   
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Figure 3.3 (con’t) 
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Figure 3.3. Chronic treatment with morphine causes loss of synaptic and 
extra-synaptic surface pHluorin-GluR1 subunits.   
A, Examples of confocal images of primary hippocampal neurons expressing pHluorin-
GluR1 (pH-GluR1) and DsRed (Left, untreated control neurons; right, morphine-treated 
neurons).  The transfected cells were imaged before (B) and after exposure to 10 μM 
morphine for various durations (3 h, 1 d and 3 d). Open arrowheads denote that both 
fluorescence intensities remained constant or even increased under untreated control 
conditions. Solid arrowheads denote that morphine progressively decreased the 
fluorescence intensity of pHluorin-GluR1 and the density of DsRed-labeled dendritic 
spines.  Scale bar, 10 μm. B, Mean pHluorin-GluR1 fluorescence from different regions 
(the entire images, spines and dendrites) of untreated (Ctl; open bars; n = 16) or 
morphine-treated neurons (Mor; black bars; n = 16) were normalized with data before 
treatments and are shown as percentages. * denotes a significant decrease comparing 
with the value before treatment. In each group, a minimum of five dendrites from a single 
neuron were analyzed. Error bars represent ± SEM. 
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Figure 3.4. The effects of morphine and CTOP on the protein level of GluR1.  
A, Representative immunoblot shows hippocampal neurons treated with or without 10 
M morphine for 1 d and 3 d.  B, Neurons were treated with or without CTOP for 1 d.  
Cells were lysed and the protein expressions of GluR1 and PSD-95 were determined by 
Western blots (A, n=3; B, n=3).  
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Figure 3.5. The effect of morphine treatment on the density of dendrtic 
spines.  
The number of spines in control (Ctl; open bars) versus morphine-treated (Mor; black 
bars) neurons was determined from the DsRed images in Figure 3.3. Morphine 
significantly decreases the density of dendritic spines after 1-3 days of treatment. * 
denotes a significant decrease comparing with the value before treatment (p < 0.05; n = 
16 in each group). Error bars represent  SEM. 
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3.1.3 Morphine-induced removal of synaptic GluR1 preceded 
morphological shrinkage of dendritic spines 
Which comes first, the loss of AMPA receptors or the loss of dendritic spines? To 
illustrate the temporal sequence of the above two processes, we compared the 
fluorescence intensities of pHluorin-GluR1 before and after the morphine treatment at 3 
h, 1 d and 3 d on dendritic spines with those of DsRed (Fig. 3.6). In the untreated 
control, the fluorescence of neither pHluorin-GluR1 nor DsRed was significantly changed 
(Fig. 3.6A, upper two panels; Fig. 3.6B, left). On the other hand, chronic application of 
morphine reduced both fluorescence of pHluorin-GluR1 and DsRed on the same spines, 
but with different time kinetics. Upon 3 h of morphine exposure, pHluorin-GluR1 
fluorescence on spines clearly decreased, whereas the DsRed signal on the spines 
remained unchanged (Fig. 3.6A, lower two panels; Fig. 3.6B, right). As mentioned the 
above, morphine has not yet caused any significant change in spine density after 3 h 
(Fig. 3.5), so the drug-induced loss of synaptic GluR1 happened before the spine 
shrinkage, suggesting that morphine-mediated loss of synaptic GluR1 was not a result of 
spine retraction, but rather a plausible cause for spine retraction. 
 
3.1.4 Morphine triggered internalization of GluR1 
The loss of the AMPA receptors on the cell surface could be a result of either an 
increase in receptor internalization or a decrease in surface recruitment of the receptor. 
To directly examine whether morphine exposure mediates endocytosis of the AMPA 
receptors, surface proteins including GluR1 in the live hippocampal cultures were  
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biotinylated prior to morphine treatment. After stripping, only internalized receptors would 
be protected and still contain biotin (see Materials and Methods, section 2.8). As shown 
in Figure 3.7A, upon application of morphine (10 μM), the amount of biotinylated GluR1 
subunits progressively increased by twofold to threefold over the control (at 12-24 h), 
indicating a time-dependent increase in internalized GluR1 subunits. However, there 
was no significant difference in the amount of the internalized NMDA receptor between 
control and morphine-treated neurons (Fig. 3.7B), suggesting that morphine specifically 
affected trafficking of GluR1 subunits. Furthermore, intracellular actin could not be 
detected in the complex pulled down by strepavidin-agarose bead (Fig. 3.7B, left panel), 
but was present in the total lysates (Fig. 3.7B, right panel), confirming that only surface-
expressed receptors can be biotinylated in our experimental model.  
 
3.2 Delineation of signaling pathways involved in regulation of      
AMPA receptor trafficking by morphine treatment 
3.2.1 The effect of morphine on AMPA receptor trafficking was mediated 
through μ-opioid receptor 
To investigate the specificity of morphine’s effect on AMPA receptor trafficking, 
hippocampal neurons overexpressing pHluorin-GluR1 and DsRed were incubated with a 
reduced dosage of morphine (1 μM) or co-treated with the selective μ-opioid receptor 
antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-ThrNH2 (CTOP) for live-cell imaging 
experiments (Fig. 3.8; Fig. 3.9). In contrast to the higher concentration of morphine (10 
μM), 1 μM morphine did not significantly reduce the fluorescence signal of synaptic 
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pHluorin-GluR1 at the 3 h time point (Fig. 3.8). Nevertheless, this lower concentration of 
morphine did induce a comparable reduction in fluorescence of the receptor at both 
spines and dendrites at longer time points (1 and 3 d) (Fig. 3.8). Hence, a higher 
concentration of morphine was likely to induce a more rapid loss of the synaptic AMPA 
receptors. More importantly, this down-regulated effect of morphine was attenuated by 
CTOP (10 μM), indicating the participation of μ-opioid receptor in morphine-modulated 
surface-expressed GluR1 (Fig. 3.9). It should be noted that both CTOP alone and CTOP 
with morphine enhanced the surface delivery of GluR1 at spines and dendrites due to 
increased fluorescence intensity in both regions (Fig. 3.9), but this did not alter the 
receptor protein expressions (Fig. 3.4). These results imply that the constitutive activity 
of μ-opioid receptor and/or endogenous opioids could regulate the distribution of AMPA 
receptors on cell surface. Consistently, biotinylation studies showed that the morphine-
induced GluR1 internalization was also blocked in the presence of CTOP (10 μM) (Fig. 
3.10). Collectively, these data indicate that morphine-induced GluR1 internalization is 
mediated by μ-opioid receptor.  
 
3.2.2 Morphine-regulated GluR1 trafficking is not caused by alteration of 
neural circuitry 
Opioid agonists have been shown to inhibit presynaptic release of transmitters such as 
GABA through activation of a voltage-dependent potassium channels. This results in a 
change in neural circuitry (Williams et al., 2001), which may indirectly contribute to the 
regulation of AMPA receptor trafficking. To test this possibility, a blockade of action 
potentials was achieved by using the sodium channel blocker Tetrodotoxin (TTX). As  
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shown in Figure 3.11A, hippocampal neurons expressing pHluorin-GluR1 and DsRed 
were imaged before and 1 day after the addition of 10 μM morphine, 1 μM TTX, TTX 
with morphine, or no drug (control). TTX was applied into cultured neurons 1 h before 
addition of morphine and was present during the course of experiment. Although 
incubation with TTX alone did not change fluorescence intensity of pHluorin-GluR1 from 
the entire images, the fluorescence intensity was significantly elevated at dendritic 
spines and diminished at dendritic shafts (entire, 107±6%; spine, 117±5%; dendrite, 
88±5%) (Fig. 3.11A, B). This suggests that TTX can cause a translocation of GluR1 
subunits from dendritic shafts to dendritic spines. Despite TTX-induced redistribution of 
GluR1 on surface membrane, application of both TTX and morphine resulted in a 
significant reduction on the fluorescence of pHluorin-GluR1 at spines and dendrites 
(entire, 76±3%; spine, 70±4%; dendrite, 60±4%) (Fig. 3.11A, B). In addition, biotinylation 
studies demonstrated that morphine still enhanced internalization of GluR1 even in the 
presence of TTX (Fig 3.11C). These findings indicate that morphine-evoked loss of 
synaptic and extra-synaptic GluR1 via the receptor internalization is not caused by 
indirect alteration in neural activity. 
  62 
 
Figure 3.11. (con’t) 
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Figure 3.11. Morphine-regulated GluR1 trafficking is not due to alterations 
of neural networks.  
A, Time-lapse images were taken on hippocampal neurons co-expressing pHluorin-
GluR1 (pH-GluR1) and DsRed before and 1 day after various treatments [untreated 
control (Ctl), 10 μM Morphine (Mor), 1 μM TTX, TTX with morphine]. Open arrowheads 
indicate that both fluorescence intensities remained constant or even increased under 
untreated control conditions.  Solid arrowheads indicate that morphine progressively 
decreased the fluorescence intensity of pHluorin-GluR1 and the density of DsRed-
labeled dendritic spines. Scale bar, 10 μM. B, Mean fluorescence intensities (fluor.) of 
pHluorin-GluR1 from different regions of neurons (entire images, spines and dendritic 
shafts) were normalized to data before treatments.  *, Significant decrease comparing 
with the value before treatment; #, Significant increase (p < 0.05, n = 15 in each group). 
C, Surface biotinylated neurons were pre-incubated with no drug (vehicle) or 1 μM TTX 
for 1 h, and then were exposed to morphine (10 μM; 1 d). Top immunoblots, internalized 
GluR1 subunits were isolated by using streptavidin precipitation and detected with an 
anti-GluR1 antibody. Bottom immunoblots, total GluR1 subunits from whole-cell lysates 
were measured for comparison. Densitometric quantifications of Western blots on the 
internalized GluR1 are shown in the bottom (normalized to the control without any drug 
treatment; * p< 0.05; n = 3). Error bars represent ± SEM. 
 
 
  64 
3.2.3 Morphine decreased phosphorylation of GluR1 at Ser845 and its 
interaction to PSD-95  
AMPA receptor trafficking and synaptic plasticity can be mediated by receptor 
phosphorylation at cytoplasmic C termini (Malinow and Malenka, 2002). To further 
investigate the molecular mechanism by which morphine regulates GluR1 
internalization, we hypothesized that morphine can affect the phosphorylation status of 
GluR1. Because activation of Gi-coupled MOR can inhibit adenylyl cyclase, decrease 
intracellular cAMP level and inactivate PKA (Duman et al., 1988; Ueda et al., 1988), we 
examined the effect of morphine on the phosphorylation status of GluR1 at Ser845 
(S845), a substrate of PKA (Esteban et al., 2003). Cultured hippocampal neurons were 
incubated with 10 μM morphine in the absence or presence of 10 μM CTOP. The GluR1 
complex was immunoprecipitated with an anti-GluR1 antibody followed by the western 
blotting detection with the phosphorylated GluR1-S845 and PSD-95 antibodies (Fig. 
3.12 and Fig. 3.13). The amount of GluR1 phosphorylation at S845 was significantly 
decreased along the duration of the morphine treatment from 3 h to 1 d, whereas the 
total amount of GluR1 was unchanged (Fig. 3.12A, B), indicating that morphine 
treatment either inhibited the phosphorylation of GluR1-S845 or enhanced the 
dephosphorylation of the receptor subunit. Meanwhile, the amount of PSD-95 in the 
receptor complex also gradually decreased when compared with the untreated neurons 
(Fig. 3.12A, B), suggesting the dissociation of GluR1 subunits from the PSD of dendritic 
spines and subsequent translocation. In contrast, co-treatment with CTOP reversed 
these effects (Fig. 3.13A, B, right), further confirming the important role of μ-opioid 
receptor in the effects of morphine. Altogether, the morphine-decreased phosphorylation 
of GluR1-S845 and morphine-induced dissociation from PSD-95 indicate a probable  
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mechanism for the opioid agonist to regulate the AMPA receptor trafficking. Therefore, to 
detect obvious GluR1 dephosphorylation, hippocampal neurons were exposed to 10 μM 
morphine for 1 d in all subsequent experiments. 
 
3.2.4 Morphine regulated GluR1 phosphorylation in a calcineurin-
dependent manner  
The phosphorylation status of GluR1-S845 depends on the balance between 
PKA and calcineurin/protein phosphatases 1 (Dell’Acqua et al., 2006). We therefore 
examined whether morphine-inhibited phosphorylation of GluR1-S845 was induced by 
suppressing the cAMP/PKA signaling pathway. Hippocampal neurons were pre-
incubated with 10 μM morphine for 3 d, followed by stimulation with a PKA activator, 
dibutyryl-cAMP (dbcAMP) for 5 and 15 min (2 mM) (Fig. 3.14A). In response to 
dbcAMP, the phosphorylation of GluR1-S845 was significantly increased at 5 min and 
further elevated at 15 min, indicating that dbcAMP-induced PKA activation stimulated 
GluR1-S845 phosphorylation in a time-dependent manner (Fig. 3.14). However, 
pretreatment with morphine caused complete and partial inhibitions of GluR1-S845 
phosphorylation induced by dbcAMP at 5 min and 15 min, respectively (Fig. 3.14). The 
complete inhibition on the effect of dbcAMP at 5 min suggests that, in the presence of 
morphine, the dephosphorylation exceeds the phosphorylation of GluR1 by PKA. The 
partial restoration by longer incubation with dbcAMP implicates that the phosphorylation 
of GluR1-S845 by PKA may overcome the phosphatase activity that morphine may 
regulate.  
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Due to the kinetics of morphine’s effect on the dbcAMP-induced GluR1-S845 
phosphorylation, we hypothesized that morphine treatment might promote 
dephosphorylation of GluR1-S845 through the activation of phosphatases. Thus, we 
examined the role of calcineurin with its specific inhibitor FK506 (Lieberman and Mody, 
1994). A concentration of FK506 at 1 μM was shown to have a significant inhibition on 
calcineurin in neuronal cells (Asai et al., 1999). Figure 3.15, A and B show the level of 
GluR1-S845 phosphorylation in untreated and morphine-treated hippocampal cultures 
with pretreatment of FK506 (1 μM; 45 min). Comparing with untreated control, exposure 
to morphine alone led to a significant decrease in GluR1-S845 phosphorylation (Fig. 
3.15A, B, left). In contrast, the pretreatment with FK506 completely attenuated the effect 
of morphine (Fig. 3.15A, B, right), suggesting that morphine-mediated 
dephosphorylation of GluR1-S845 is dependent on calcineurin.  
To further support this conclusion, we performed an in vitro phosphatase assay 
to determine whether morphine exposure can increase the activation of calcineurin. 
Hippocampal neurons were treated with 10 μM morphine for various durations before 
cell lysis (Fig. 3.16). To establish an assay condition in which the activity of calcineurin 
can be examined clearly, okadaic acid (100 nM), an inhibitor for phosphatase 1 and 2A, 
was included in all assay buffers (as described in Materials and Methods, section 2.9) 
(Fruman et al., 1996). As shown in Figure 3.16, phosphatase activity markedly 
increased 30 minutes after morphine application and persisted during 1 d of morphine 
treatment (30 min, 147 ± 11%; 1 h, 141 ± 9%; 3 h, 140 ± 5%; 6 h, 142 ± 3%; 1 d, 160 ± 
14%) (Fig. 3.16). However, this effect of morphine was eliminated, when             
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FK506 (1 μM) was added to the assay buffers (30 min, 100 ± 7%; 1 h, 110 ± 5%; 3 h, 
100 ± 8%; 6 h, 98 ± 12%; 1 d, 106 ± 6%) (Fig. 3.16), indicating that the increase in 
phosphatase activity due to morphine is primarily activation of calcineurin. This 
morphine-induced calcineurin activation was totally suppressed by co-treatment with 
CTOP as well (Fig. 3.17). Together, these results suggest that morphine acts through μ-
opioid receptor to increase the activity of calcineurin, which in turn promotes 
dephosphorylation of GluR1-S845.  
 
3.2.5 Morphine-induced calcineurin activation and GluR1-S845 
dephosphorylation is independent of NMDA receptors 
Calcineurin is a Ca2+-dependent protein phosphatase (Klee et al., 1979), and has been 
shown to be activated by Ca2+ influx through NMDA receptors (Li et al., 2002). Because 
morphine is reported to alter protein expression and functional property of NMDA 
receptors in vivo (Inoue et al., 2003; Ma et al., 2007; Yang et al., 2000), which may 
change the intracellular concentration of Ca2+, we evaluated the participation of NMDA 
receptor in morphine-regulated calcineurin activity and GluR1-S845 dephosphorylation. 
DL-APV (100 μM), a NMDA receptor antagonist, was applied 1 h before treatment with 
morphine. We found that morphine still increased calcineurin activity and decreased 
GluR1-S845 phosphorylation in neurons pretreated with DL-APV when compared with 
neurons without drug pretreatment (Fig. 3.17 and Fig. 3.18A). Therefore, the 
contribution of NMDA receptors to the morphine’s effect is excluded. In agreement with 
the data in Figure 3.11, application of TTX did not affect the morphine-induced 
calcineurin activation (Fig. 3.17) and GluR1-S845 dephosphorylation (Fig. 3.18B), 
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further verifying that the calcineurin-dependent GluR1-S845 dephosphorylation is not an 
indirect consequence of altered neural network by morphine.  
 
3.2.6 Calcineurin plays an important role in morphine-regulated GluR1 
trafficking 
To explore the participation of calcineurin in morphine-regulated GluR1 
endocytosis, surface-biotinylated hippocampal cultures were incubated with FK506 (1 
μM) for 45 min prior to morphine exposure (10 μM; 1 day) (Fig. 3.19). Compared with 
the untreated control, the 2.5-fold increase of the GluR1 internalization by morphine was 
completely blocked in the presence of FK506 (Fig. 3.19), suggesting an essential role of 
calcineurin in morphine-induced GluR1 endocytosis. To verify the involvement of 
calcineurin in morphine-induced loss of surface-expressed GluR1, hippocampal neurons 
over-expressing pHluorin-GluR1 and DsRed were imaged before and after treatment 
with no drug (control), morphine, FK506 or FK506 with morphine (Fig. 3.20). Upon 
morphine treatment alone (10 μM for 1 day), the averaged fluorescence of pHluorin-
GluR1 from the entire image, spines and dendrites was significantly reduced (Fig. 3.20), 
revealing the removal of synaptic and extra-synaptic GluR1. In contrast, pretreatment 
with FK506 (1 μM, 45 min) attenuated the morphine-induced decrease in pHluorin-
GluR1 on spines and dendrites (Fig. 3.20). These data demonstrated that morphine 
regulates AMPA receptor trafficking primarily through a calcineurin-dependent pathway.   
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Figure 3.18. (con’t) 
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Figure 3.18. There was no influence of DL-APV and Tetrodotoxin on 
morphine-induced GluR1-S845 dephosphorylation.  
Hippocampal neurons were pretreated with no drug, 100 μM DL-APV (A) or 1 μM TTX 
(B) for 1 hour and then were exposed to morphine (10 μM) for 1 day. Cell lysates were 
immunoprecipiated by an anti-GluR1 antibody and the pull-down complexes were 
immunoblotted using antibodies against phospho-GluR1-S845 (top) and GluR1 (middle). 
Total GluR1 from whole cell extracts (Input) was also detected (bottom). Bar charts in 
show densitometric quantifications of western blots on the level of phosphorylated 
GluR1-S845 (normalized to the control without any drug treatment). * denotes a 
significant decrease in GluR1-S845 phosphorylation upon morphine treatment (p < 0.05; 
n = 4). Error bars represent ± SEM. 
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          As mentioned in section 3.2.5, it seems that the activation of NMDA receptors is 
not essential for GluR1-S845 dephosphorylation by morphine (Fig. 3.18A). Thus, their 
involvement in the morphine-regulated GluR1 internalization is not expected, if 
dephosphorylation at Ser845 is associated with GluR1 internalization. To confirm this, DL-
APV was applied before morphine treatment to inhibit NMDA receptors in experiments of 
live-cell imaging (Fig. 3.21A, B) and surface biotinylation (Fig. 3.21C). Figure 3.21 A 
and B shows that although DL-APV pretreatment (100 μM; 1h) slightly but not 
significantly facilitated redistribution of pHluorin-GluR1 from dendrites to spines, 
morphine still triggered a great removal of synaptic and extrasynaptic pHluorin-GluR1.  
Furthermore, DL-APV also had no influence on morphine-induced GluR1 endocytosis 
(Fig. 3.21C). All of these results suggest that morphine regulates GluR1 phosphorylation 
at Ser845 and trafficking in a NMDA receptor-independent manner.  
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Figure 3.21. (con’t) 
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Figure 3.21.  DL-APV does not affect the morphine-regulated GluR1 
trafficking.  
A, Neurons co-expressing pHluorin-GluR1 and DsRed were imaged before (left) and 1 
day (right) after treatment with no drug (Ctl), 10 μM morphine (Mor), 100 μM APV or 
APV with morphine. Open arrowheads denote no change in pHluorin-GluR1 
fluorescence and spine morphology. Solid arrowheads denote a decrease in the 
pHluorin-GluR1 fluorescence and spine morphology by morphine.  Scale bar , 10 μm. B, 
Averaged fluorescence of pHluorin-GluR1 from different regions of neurons (entire 
image, spines and dendritic shafts) were normalized to values before treatment in the 
four groups of experiments (no drug, morphine, APV, and APV with morphine). * p < 
0.05, comparing with data before treatment. At least five dendrites of single neurons 
were analyzed (n = 12 in each group). (C) Surface biotinylated hippocampal neurons 
were pre-incubated with no drug (vehicle) or 100 μM DL-APV (right) for 1 h, and then 
exposed to morphine (10 μM; 1 day). Top immunoblot, The internalized GluR1 subunits 
were precipitated with streptavidin and detected with an anti-GluR1 antibody. Lower 
immunoblot, Total GluR1 subunits from whole-cell lysates were detected for comparison. 
A graph shows densitometric quantifications of western blots on the internalized GluR1 
(normalized to the control without any drug treatment; * p< 0.05; n = 3). Error bars 
represent ± SEM. 
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3.2.7 Dephosphorylation of GluR1-S845 was essential for morphine-
induced GluR1 internalization 
To directly test the involvement of calcineurin-dependent GluR1-S845 
dephosphorylation in the regulation of GluR1 trafficking by morphine, we generated a 
GluR1 mutant, in which the Ser845 residue was mutated to a negatively charged aspartic 
acid (S845D) to mimic continuous phosphorylation of AMPA receptors (Boehm et al., 
2006). Hippocampal cultures over-expressing either GFP-GluR1 wild-type or GFP-
GluR1-S845D mutant were subjected to biotinylation before morphine treatment (10 μM 
for 1 day) (Fig. 3.22). Internalized recombinant receptors (about 127 kDa) were detected 
by an anti-GFP antibody, and internalized endogenous GluR1 (about 100 kDa) was 
determined by an anti-GluR1 antibody (Fig. 3.22A, top and middle immunoblots). Equal 
protein amounts of both recombinant and endogenous receptors from each sample were 
also validated by the anti-GluR1 antibody (Fig. 3.22A, bottom immunoblot). Without drug 
treatment, we found a trend that the basal amount of internalized GFP-GluR1-S845D 
mutant was slightly less than that of internalized GFP-GluR1 wild-type, but this did not 
reach statistical significance (wild-type, 100%; S845D, 90±7.8%) (Fig. 3.22B, left panel). 
Morphine treatment enhanced internalization of GFP-GluR1 wild-type, but not the GFP-
GluR1-S845D mutant (wild-type/morphine, 174±12.1%; S845D/morphine, 87±12.3%) 
(Fig. 3.22A, top immunoblot; Fig. 3.22B, left panel). This suggests that the 
dephosphorylation of GluR1-S845 is important for morphine to regulate the AMPA 
receptor endocytosis. The effect of morphine on endogenous GluR1 was used as a 
positive control, in which morphine was able to induce a significant internalization of 
endogenous GluR1 regardless of whether the cells were transfected with GFP-GluR1 
wild-type or S845D mutant (Fig. 3.22A, middle immunoblot; Fig. 3.22B, right panel).  
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Nevertheless, in the presence of the receptor mutant, the endogenous GluR1 was 
internalized by morphine to a lesser extent than that in the presence of wild-type (from 
178±10.2% to 144±10.3%) (Fig. 3.22B, right panel), implying that some endogenous 
GluR1 might form a functional receptor unit with the recombinant receptor.  
To further confirm the above biochemical studies, live-cell imaging experiments 
were also carried out with employing both pHluorin-GluR1-S845D and pHluorin-GluR1-
S845A. The pHluorin-GluR1-S845A is a phospho-blocking mutant carrying a substitution 
of Ser845 with neutral amino acid, alanine (S845A). It is expected that both mutants are 
unable to be further dephosphorylated (Man et al., 2007). Therefore, hippocampal 
neurons were co-transfected with DsRed and either pHluorin-GluR1 wild-type, pHluorin-
GluR1-S845D or pHluorin-GluR1-S845A. The transfected cells subsequently were 
imaged before and 1 day after morphine treatment (10 μM) (Fig. 3.23; Fig. 3.24). No 
obvious morphological difference was observed among cells over-expressing wild-type 
and mutant receptors (Fig. 3.23A; Fig. 3.24A). This is similar to the findings of earlier 
studies that mimicking GluR1 phosphorylation or dephosphorylation at Ser845 does not 
significantly change surface or synaptic GluR1 levels (Kessels et al., 2009; Lee et al., 
2003). In the pHluorin-GluR1 wild-type labeled cells, morphine significantly decreased 
the averaged green fluorescence from the entire images, spines and dendrites (Fig. 
3.23B; Fig. 3.24B). In contrast, morphine did not alter the green fluorescence intensity 
when the cells were overexpressed with either pHluorin-GluR1-S845D or pHluorin-
GluR1-S845A (Fig. 3.23B; Fig. 3.24B), demonstrating that morphine-induced AMPA 
receptor internalization can be blocked by both phospho-mimic S845D and S845A 
phospho-blocking mutants. Since both mutants can provide a constant phosphorylation 
status of GluR1 and they are effective in suppressing morphine-induced GluR1 
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trafficking, this suggests that a change in GluR1 phosphorylation by morphine is required 
for the regulation of receptor trafficking. It is possible that an induction of receptor 
dephosphorylation itself may send a downstream signal transduction to trigger or 
modulate AMPA receptor internalization.   
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Figure 3.23. (con’t) 
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Figure 3.23. The effect of GluR1-S845D phosphomutant on morphine-
reduced surface AMPA receptors.  
A, Neurons co-expressing DsRed and pHluorin-GluR1-WT (top) or pHluorin-GluR1-
S845D (bottom) were imaged before (left) and after morphine (Mor) treatment (right, 10 
mM for 1 day). Open arrowheads denote no change in pHluorin-GluR1 and spine 
morphology. Solid arrowheads denote loss of surface pHluorin-GluR1 (green 
fluorescence) and shrinkage of spines (DsRed fluorescence) by morphine. Scale bar, 10 
mm. B, Averaged fluorescence (fluor.) of pHluorin-GluR1 from different regions of 
neurons (entire image, spines and dendritic shafts) were normalized to values before 
treatment in the four groups of experiments (WT/Ctl, overexpression of pHluorin-GluR1 
WT with no drug; WT/Mor, pHluorin-GluR1 WT with morphine; S845D/Ctl, pHluorin-
GluR1-S845D with no drug; S845D/Mor, pHluorin-GluR1-S845D with morphine). * p < 
0.05, compared with data before treatment. At least 5 dendrites of single neurons were 
analyzed (n = 13 in each group). Error bars represent ± SEM.  
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Figure 3.24. (con’t) 
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Figure 3.24. Overexpression of pHluorin-GluR1-S845A mutant blocked the 
morphine-regulated AMPA receptor internalization. A, Neurons coexpressing 
DsRed and pHluorin-GluR1-WT (top) or pHluorin-GluR1-S845A (bottom) were imaged 
before (left) and after (right) morphine treatment (10 μM for 1 day). Open arrowheads 
denote no change in pHluorin-GluR1 and spine morphology. Solid arrowheads denote 
loss of surface pHluorin-GluR1 (green fluorescence) and shrinkage of spines (DsRed 
fluorescence) by morphine. Scale bar, 10 μm. B, Averaged fluorescence of pHluorin-
GluR1 from different regions of neurons (entire image, spines and dendritic shafts) were 
normalized to values before treatment in the four groups of experiments (WT/Ctl,  
overexpression of pHluorin-GluR1-WT with no drug; WT/Mor, pHluorin-GluR1-WT with 
morphine; S845A/Ctl, pHluorin-GluR1-S845A with no drug; S845A/Mor, pHluorin-GluR1-
S845A with morphine). * p < 0.05, comparing with data before treatment. At least five 
dendrites of single neurons were analyzed (n = 10 in each group). Error bars represent ± 
SEM. 
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3.3 Investigation of a functional role of GluR1 trafficking in 
morphine-induced addictive behaviors 
Dynamic AMPA receptor trafficking contributes to synaptic plasticity including 
LTP and LTD, which in turn serve as a cellular model of learning and memory. Given 
that drug addiction occurs as a function of experience, its pathological form is closely 
related to these cognitive functions (Nestler, 2002; Kelley 2004). For example, a memory 
of drug experience is triggered when abusers are exposed to the environmental context 
previously associated with the drug availability. This context-dependent memory still 
exists even after long period of abstinence and is believed to motivate drug craving or 
drug-seeking behaviors, thereby increasing the risk of relapse (O’Brien et al., 1992; 
Childress et al., 1999; Hyman, 2005). In the last part of this study, we sought to 
investigate the functional role of the morphine-mediated GluR1 phosphorylation and 
endocytosis in the behavioral manifestation of opiate addiction, particularly the drug-
induced contextual learning and memory.  To do that, a line of homozygous mutant 
mouse in which the Ser845 on the GluR1 subunit is mutated to Ala (S845A) (Lee et al., 
2010) was employed in a behavioral test for context preference, called conditioned place 
preference (CPP).  
 
3.3.1 Morphine-regulated GluR1 phosphorylation and internalization was 
abolished in GluR1-S845A mutant mice 
To determine the effect of morphine on the AMPA receptor trafficking in 
homozygous GluR1-S845A mutant mouse, internalization of AMPA receptors were 
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measured by the surface biotinylation assay in cultured hippocampal neurons from the 
wild-type (WT) and the mutant mice. The surface proteins in live cells were biotinylated 
before treatment with 3 μM or 10 μM morphine for 1 day (Fig. 3.25). In WT neurons, 
either 3 μM or 10 μM morphine for 1 d induced a significant increase in GluR1 
endocytosis compared to control neurons without any drug treatment (Fig. 3.25). In 
contrast, morphine exposure had no influence on the receptor endocytosis in GluR1-
S845A homozygous mutant neurons (Fig. 3.25). Moreover, phosphorylation of GluR1 at 
Ser845 and total amount of GluR1 from the whole-cell lysates were detected as well (Fig. 
3.25A). Consistent with the above results obtained from rat hippocampal neurons (Fig. 
3.12), dephosphorylation of GluR1 at Ser845 by morphine (3 μM and 10 μM for 1 d) was 
also observed in mouse WT cultures (Fig. 3.25A). As Ala residue was to substitute 
Ser845 on the GluR1 in mutant neurons, no protein signal could be detected with the 
antibody against phospho-GluR1-S845 by Western blotting (Fig. 3.25A). Altogether, 
these results confirm that the morphine’s effects on GluR1 phosphorylation and 
endocytosis are attenuated in the GluR1-S845A homozygous mutant mice.  
 
3.3.2 A decreased sensitivity to morphine-induced conditioned place 
preference in GluR1-S845A mutant mice 
CPP paradigm involves pairing the effect of drugs with certain environmental 
cues provided by an experimental apparatus. CPP test hence measures the rewarding 
property of the drugs by assessing the acquisition of animals’ preference for the drug-
associated cues. The experimental apparatus comprises two main compartments and 
each of them gives different visual and tactile cues (Fig. 2.1 in section 2.10.2, Material  
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and Methods). Figure 3.26A shows timeline of the CPP experiment. During the training 
period, each of the mice would be given two 40-min conditioning sessions per day (at 
least 4h apart). In the first session, all mice were injected with saline subcutaneously 
(s.c.) and confined in the specified compartments. In the second session on the same 
day, one-half of them received morphine and the other half had saline, and they were 
placed in the other compartments. One day after conditioning period, the animals were 
tested in a drug-free state and were allowed with free access to the whole apparatus for 
15 min. The amount of time the animals spending in the compartment paired with 
morphine serves as a measure of preference acquisition. First, we investigated the CPP 
responses of WT and GluR1-S845A mutant mice, which were conditioned with morphine 
at 5 mg/kg, 10 mg/kg or saline (s.c.) for two consecutive days (Fig. 3.26B). By 
comparing with the saline-injected control, both WT and GluR1-S845A mutant mice 
acquired a comparable CPP upon treatment of morphine at 5 mg/kg (CPP scores: WT, 
109 ± 49 s; S845A, 109 ± 36 s; P > 0.05; n = 8) (Fig. 3.26B). Nevertheless, the injection 
of a higher dose of morphine (i.e. 10 mg/kg) for two days of conditioning caused a 
further increase of CPP only in the WT animals, but not in the mutant animals. The effect 
of the higher dose of morphine was significantly greater in the WT than that of GluR1-
S845A mutants (WT, 197 ± 17 s; S845A, 121 ± 22 s; P < 0.01; n = 20) (Fig. 3.26B), 
suggesting a different sensitivity to morphine-induced CPP between genotypes. These 
results were further confirmed by using four consecutive days of morphine conditioning 
(Fig. 3.26C). After four days of conditioning in WT mice, 5 mg/kg morphine treatment 
was sufficient to induce CPP acquisition compared to that induced by 10 mg/kg 
morphine. However, 5 mg/kg morphine-induced CPP expression in GluR1-S845A 
mutants was significantly lower than that of the WT mice (S845A, 125 ± 24 s; WT, 202 ± 
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20 s; P < 0.05; n = 15), although CPP responses to 10 mg/kg morphine in the mutant 
and WT mice were not significantly different (S845A, 200 ± 19 s; WT, 208 ± 22 s; P > 
0.05; n = 12) (Fig. 3.26C). Therefore, GluR1-S845A mice exhibited a reduced sensitivity 
to CPP at a lower dose of morphine or shorter duration of morphine conditioning.  
The decreased response to morphine CPP in GluR1-S845A mutants may be a 
result of their abnormal locomotor activity or deficit in contextual learning. We therefore 
compared locomotor activity between genotypes during the CPP training (section 2.10.2, 
Materials and Methods). Their locomotor activities are shown in Figure 3.27. by mean 
total distance they travelled (in 40 min) and their velocity of movement. Statistical 
analysis indicated that saline-injected WT and GluR1-S845A mutants did not 
significantly differ in locomotion activity (WT/distance, 30 ± 1.5 m; S845A/distance, 34 ± 
1.6 m; P > 0.05) (WT/velocity, 2.5 ± 0.17 cm/s; S845A/velocity, 2.9 ± 0.17 cm/s; P > 
0.05) (Fig. 3.27). Furthermore, upon administration with 10 mg/kg morphine both of 
them increased their distance travelled and velocity in similar magnitudes (WT/distance, 
194 ± 12 m; S845A/distance, 176 ± 9.9 m; P > 0.05) (WT/velocity, 10 ± 0.7 cm/s; 
S845A/velocity, 9.3 ± 0.8 cm/s; P > 0.05) (Fig. 3.27). These results indicate that the 
mutation of S845A has no influence on animals’ baseline and morphine-evoked 
locomotion. To evaluate animals’ spatial learning and memory, a hippocampus-
dependent task, Morris water maze, was used (Morris, 1984). In the test, rodents 
navigate in an open swimming tank by using visual cues to locate an escape platform, 
and the time taken to reach the platform (escape latency) is a measure of animals’ 
spatial acquisition. During the first two days of training, WT and S845A mutant mice had 
comparable escape latencies, indicating that both genotypes started at the same level of 
performance to learn the location of the platform (Fig. 3.28). Furthermore, their escape 
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latencies across other successive days (Day 3 to Day 6) were decreasing at almost the 
same rates (Fig. 3.28). This similar improvement in performance between groups for 
searching the hidden platform suggests that the GluR1-S845A mutation did not affect 
regular contextual learning and memory behavior.  Collectively, it appears that a 
decrease in morphine CPP by GluR1-S845A mutation is not related to abnormal 
locomotion or contextual learning deficits.  
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Figure 3.26. A comparison of CPP acquisition between wild-type and 
GluR1-S845A homozygous mutant mice.  
A, The experimental timeline for Conditioned Place Preference (CPP). CPP paradigm 
includes 4 phases: habituation, preconditioning test, saline or morphine conditioning and 
CPP test. It should be noted that the conditioning involves consecutive two or four days.  
B and C, GluR1-S845A mutation reduces the sensitivity to morphine-CPP. Wild type 
(WT) and GluR1-S845A mutant (S845A) mice were conditioned with either 5 mg/kg or 
10 mg/kg morphine administration for consecutive two days (B) or four days (C). CPP 
score is calculated by subtracting the time mice spent in the morphine-paired chamber 
before conditioning from that after conditioning. *, Significant difference on CPP 
acquisition between WT and S845A mutants (P < 0.05). Error bars represent ± SEM.  
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3.3.3 GluR1-S845A mutation impaired extinction of morphine CPP 
To examine the persistence of morphine-associated contextual memory in the 
GluR1-S845A mutant mice, we performed a series of extinction tests on mice 
conditioned with 10 mg/kg morphine for consecutive four days, in which both WT and 
mutants exhibited robust and similar CPP responses. Although both genotypes started 
at similar morphine CPP (WT, 200.7 ± 15 s; S845A, 186 ± 12.4 s; P > 0.05; n = 30) (Fig. 
3.29), the CPP response in WT but not GluR1-S845A mutants was significantly reduced 
after 9 extinction tests (WT, 124.7 ± 21.3 s; S845A, 169.9 ± 19.5 s) (Fig. 3.29). During 
11st test session, the reduction of CPP expression in WT was significantly greater than 
that of GluR1-S845A mutant mice (WT, 93.13 ± 18.4 s; S845A, 152.6 ± 19.5 s; P = 0.03; 
n = 28) (Fig. 3.29). Finally, CPP expression observed with the WT mice was completely 
extinguished after 15 test sessions, whereas the CPP response of GluR1-S845A 
mutants was extinguished after 23 sessions (Fig. 3.29). These findings suggest that the 
S845A mutation either impaired the learning of the new conditioning or prolonged the 
retention of the old conditioning with morphine. 
Taken together, all of the above results suggest that an alteration in GluR1 
phoshorylation at Ser845 and subsequent receptor endocytosis are involved in acquisition 
and extinction of morphine CPP, which might reflect the AMPA receptor’s involvement in 
the mechanisms underlying opiate-seeking behaviors.   
  101 
 
 
 
  102 
 
 
 
 
CHAPTER 4 
DISCUSSION 
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4.1 Morphine-induced internalization of AMPA receptors 
Earlier electrophysiological studies on hippocampal cultures have demonstrated 
that chronic exposure to morphine decreases the amplitude of mEPSCs (Liao et al., 
2005; Liao et al., 2007), which can be attributed to a removal of pre-existing AMPA 
receptor, an inhibition in synaptic delivery of the receptor, and/or a suppression of the 
receptor channel opening. In the current study, time-lapse imaging and biochemical 
experiments provided direct evidence that morphine treatment induced a time-
dependent loss of pre-existing GluR1 at both spines and dendrites, likely through 
receptor internalization (Figs. 3.3, 3.7). However, the receptor internalization may not be 
the exclusive mechanism, as rats administrated with morphine have a marked reduction 
of LTP at hippocampi (Pu et al., 2002), which suggests a decrease in the re-insertion 
rate of synaptic AMPA receptors. Therefore, it is plausible that morphine-induced loss of 
postsynaptic GluR1 is a combination of increased internalization and decreased synaptic 
delivery (Ehlers, 2000; Man et al., 2007). Moreover, it should be noted that the loss of 
surface pHluorin-GluR1 could be detected by live-imaging 3 h after morphine treatment 
(Fig. 3.3), but an increase in endogenous internalized GluR1 appeared only after 6 h, as 
shown in the biochemical experiments (Fig. 3.7). This time discrepancy may be due to 
different sensitivity of the two analysis techniques. The live imaging is based on 
detection of overexpressed recombinant receptors in a single neuron, while the 
biochemical study measures endogenous receptors in a population of neurons. Hence, 
the imaging technique may have higher sensitivity to detect subtle changes in the 
receptor movement at an earlier time point.  
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Morphine is well known to inhibit the presynaptic release of GABA through 
activation of inwardly rectifying potassium channels and suppression of calcium 
channels in GABAergic neurons of hippocampus, leading to a disinhibition of neural 
circuits (Wimpey and Chavkin, 1991). Since TTX pretreatment, which prevents 
depolarization cannot attenuate morphine-induced GluR1 endocytsis and loss of 
surface-expressed GluR1 (Fig. 3.11), the morphine effect in cultured hippocampal 
neurons is not due to an alteration of the neural network. Notably, CTOP co-treatment 
can totally abrogate the morphine-induced AMPA receptor trafficking (Figs. 3.9, 3.10).  
In addition, previous studies have found that μ-opioid receptors predominantly express in 
postsynaptic membrane (Arvidsson et al., 1995; Liao et al., 2005) and mainly co-
localized with postsynaptic AMPA receptors (Liao et al., 2005). All of these observations 
suggest that morphine likely acts on postsynaptic μ-opioid receptors to regulate AMPA 
receptor trafficking. 
 
4.2 Morphine regulates dephosphorylation of GluR1 at Ser845 
and GluR1 endocytosis in a calcineurin dependent manner 
We found that prolonged application of morphine promotes the 
dephosphorylation of GluR1 at Ser845 and reduces the amount of PSD-95 in the 
immunoprecipitated GluR1 complex (Figs. 3.12, 3.13), indicating the detachment of 
GluR1 from the PSD. Importantly, the prevention of GluR1-S845 dephosphorylation by 
either GluR1-S845D or -S845A mutant clearly suppresses the morphine-induced GluR1 
endocytosis (Figs. 3.22, 3.25). These observations are consistent with the prevalent 
view that the phosphorylation of AMPA receptors can regulate the receptor trafficking by 
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affecting the interactions between the receptors’ cytoplasmic tails and postsynaptic 
scaffolding proteins, especially PDZ-domain containing proteins such as SAP97, PSD-
95, GRIP/ABP and PICK (Dong et al., 1997; Leonard et al., 1998; Xia et al., 1999; 
Shepherd and Huganir, 2007). As our results suggest that an alteration of 
phosphorylation status of GluR1-S845 by calcineurin-induced dephosphorylation is 
important for morphine-regulated GluR1 trafficking (Figs. 3.22, 3.23, 3.24), this implies 
that the induction of dephosphorylation can facilitate the dissociation of the GluR1 
cytoplasmic tails and postsynaptic scaffolding proteins. Furthermore, since AMPA 
receptors are believed to cluster in PSD of synapses via the binding of stargazin or 
related transmembrane AMPAR binding proteins (TARPs) to PSD-95 (Nicoll et al., 
2006), it will be of interest to determine whether GluR1-S845 dephosphorylation by 
morphine affects the interaction between AMPA receptors and TARPs or TARPs and 
PSD-95, and how the dephosphorylation suppresses this interaction.   
The net level of GluR1-S845 phosphorylation depends on the opposing activities 
of PKA and phosphatases such as calcineurin (Barria et al., 1997; Beattie et al., 2000). 
Since postsynaptic protein A kinase-anchoring protein 150 (AKAP150) can scaffold PKA 
and calcineurin at different binding sites and is recruited to the complexes of SAP-
97/PSD-95 and GluR1, AKAP150 acts as a link to position these intracellular enzymes 
adjacent to the surface receptors. The physical proximity of these proteins in turn allows 
PKA and calcineurin to regulate GluR1-S845 phosphorylation in a highly coordinated 
manner (Colledge et al., 2000, Dell’Acqua et al., 2006). In this study, 3 days of morphine 
treatment only elicits a transient reduction on GluR1-S845 phosphorylation by db-cAMP 
(Fig. 3.14), suggesting that morphine-induced PKA inhibition alone is insufficient to 
reduce GluR1-S845 phosphorylation level. Conversely, FK506 pretreatment completely 
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reverses the morphine-induced GluR1-S845 dephosphorylation and morphine is able to 
increase calcineurin activity (Figs. 3.15, 3.16), indicating that activated calcineurin 
appears to be the dominant regulator of GluR1-S845 phosphorylation when the primary 
hippocampal neurons were treated with morphine.  
Recently, several in vivo studies have found that discontinuous treatment of 
animals with morphine increases GluR1-S845 phosphorylation, in contrast to our 
findings (Billa et al., 2009; Billa et al., 2010). This difference may be related to different 
experimental models, particularly the method of morphine application. They used a 12-hr 
period without morphine injections before animal dissection, potentially leading to a 
decrease in morphine level by metabolism and elimination. The decreased morphine 
level may cause drug withdrawal that in turn increases adenylate cyclase activity, cAMP 
level and PKA activity (Sharma et al., 1975). Once PKA activity overwhelms calcineurin 
activity, GluR1-S845 phosphorylation level could then be increased. In contrast, our 
study employed a continuous incubation of hippocampal cultures with morphine, in 
which PKA was inhibited, thus favoring the action of activated calcineurin (Figs. 3.14, 
3.15, 3.16). As a result, there was dephosphorylation of GluR1-S845. Furthermore, our 
in vitro primary culture studies were also not affected by the circuitry synaptic activities 
as shown in our TTX and APV studies, which might not be case in the in vivo studies if 
the animals treated with morphine were undergoing withdrawal.  Hence, cultured 
hippocampal neurons can provide an experimental model to directly study any neuro-
modulation induced by morphine itself or μ-opioid receptors.  
             Calcineurin is a Ca2+-dependent protein phosphatase (Klee et al., 1979), and it 
plays a pivotal role in morphine-regulated GluR1-S845 dephosphorylation at Ser845 and 
receptor endocytosis (Figs. 3.15, 3.19, 3.20). The key issue is how calcineurin is 
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stimulated or where Ca2+ comes from upon morphine treatment. Although the precise 
mechanism underlying morphine activated calcineurin in our study is still unclear, at 
least we narrow down the pathway that NMDA receptors are not involved, as DL-APV 
has no effect on morphine-increased calcineurin activity (Fig. 3.17). Apart from NMDA 
receptors, other glutamate receptors such as Gq-coupled metabotropic glutamate 
receptors (mGluRs) and the related intracellular messengers such as phospholipids-
Ca2+-PKC are believed to regulate morphine-induced signal transduction in vitro and 
tolerance development in vivo (Chu et al., 2010; Narita et al., 2005; Fundytus and 
Coderre, 1996). Therefore, mGluRs or/and phospholipid-Ca2+-PKC may be the potential 
signal pathways mediating the calcineurin activation. Considering a recent report that 
Ca2+-permeable AMPA receptor is absent from perisynaptic sites in GluR1-S845A 
mutant mice (He et al., 2009), and our data that overexpression of pHluorin-GluR1-
S845A causes the attenuation of morphine-regulated GluR1 trafficking (Figs. 3.24, 
3.25), Ca2+-permeable AMPA receptor may be another potential source of Ca2+ 
activating calcineurin.  
 
4.3 Implications of morphine-regulated GluR1-containing 
AMPA receptors trafficking 
The present study directly demonstrates that chronic treatment with morphine 
induces GluR1 endocytosis, resulting in a loss of GluR1 at excitatory synapses of 
hippocampi (Figs. 3.3, 3.7). This morphine effect may represent a key step in an 
addiction model proposed by Lüsher and Bellone (2008). In this model, chronic exposure 
to addictive drugs such as cocaine will induce an initial synaptic plasticity, in which the 
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amount of synaptic AMPA receptors in nucleus accumbens initially decreases (Thomas 
et al., 2001). However, later withdrawal of the drug increases synaptic insertion of the 
receptors, even exceeding the baseline. Intriguingly, Ca2+-impermeable-AMPA receptors 
are gradually replaced by Ca2+-permeable ones during the late withdrawal (Conrad et al., 
2008). Such exchange for Ca2+-permeable AMPA receptors is considered to conduct 
synaptic currents more readily and to contribute long-lasting alterations in synaptic 
strength that implies the relapse of addiction. This multiple-step addiction model 
emphasizes that the addictive drugs-evoked synaptic plasticity indeed is a hierarchical 
organization: an initial induction of synaptic plasticity is important for developing 
subsequent plasticity (Lüsher and Bellone, 2008). Therefore, chronic exposure to 
morphine-induced removal of synaptic GluR1 is probably the initial induction of plasticity 
that may underlies the drug addiction. This speculation provoked us to examine the 
physiological significance of morphine-regulated AMPA receptor trafficking in the 
hippocampus for opioid addictive behaviors, which will be discussed below. Since the 
hippocampus is a vital part of the brain responsible for learning and memory, our work 
emphasized on the formation of the memory for the environmental context of the drug 
experience, like CPP paradigm that contributes to drug seeking and relapse behaviors 
(Hyman et al., 2006).  
 
4.4 Potential involvement of synaptic plasticity in the 
alterations of acquisition and extinction of morphine CPP 
by impaired change in GluR1 phosphorylation at Ser845  
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 The phenotype of homozygotes of GluR1-S845A mutant mice used in the current 
behavioral study has been well examined (He et al., 2009; Lee et al., 2010). They not 
only express normal levels of total GluR1 proteins and cell surface GluR1 (He et al., 
2009), but also have no deficit in constitutive receptor internalization under basal 
conditions, the basal synaptic transmission and presynaptic function (Lee et al., 2003; 
Lee et al., 2010), therefore implying that no dramatic functional compensation occur in 
this transgenic model to mask the specific role of GluR1 phosphorylation at Ser845. 
Although the phosphorylation of GluR1-S845 is critical for extra-synaptic insertion of 
GluR1-containing AMPA receptor, these mutant mice still have no abnormalities in 
induction, magnitude and stability of LTP (Lee et al., 2010), suggesting other 
phosphorylation sites such as S831 can support LTP. Interestingly, they display 
significant impairment on NMDA receptor activation-induced AMPA receptor endocytosis 
and LTD (Lee et al., 2010; He et al., 2009). Given that morphine-induced GluR1 
endocytosis was attenuated in cultured hippocampal neurons from GluR1-S845A 
mutants (Fig. 3.25) and the evidence for the role of dynamic GluR1 trafficking in 
mediating strength in hippocampal glutamatergic synapses is compelling, it is plausible 
that the GluR1-S845A mutation may alter synaptic plasticity evoked by morphine and the 
drug-related contextual experience, such as hippocampus-dependent CPP paradigm.  
 Previous reports showed that contextual learning such as inhibitory avoidance 
learning requires synaptic insertion of GluR1-containing AMPA receptors and synaptic 
potentiation in hippocampus (Whitock et al., 2006; Kessels and Malinow, 2009; 
Mitsushima et al., 2011). Consistent to these observations, synaptic potentiation by 
GluR1 trafficking has been suggested to play an important role in addictive drugs-
associated learning and memory (Kauer and Malenka, 2007). For instance, CPP and 
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conditioned locomotor responses to cocaine, but not behavioral sensitization, were 
impaired in adult GluR1 knockout mice, in which LTP is essentially abolished (Dong et 
al., 2004; Zamanillo et al., 1999; Mack et al., 2001). As mentioned before, the GluR1-
S845A mutant mice exhibited normal LTP in comparison to WT, suggesting no deficit in 
synaptic GluR1 delivery. This may explain why the GluR1-S845A mutant mice displayed 
acquisition of morphine CPP comparable to WT after undergoing the maximum amount 
of training in our study (i.e. 4 days of conditioning with 10 mg/kg morphine) (Fig. 3.26). 
Nevertheless, our results showing decreased sensitivity to acquire morphine CPP in 
GluR1-S845A mutant mice (Fig. 3.26) may be related to the alterations of neural 
plasticity driven by morphine and/or the drug-associated contextual experience in the 
mutants. As the GluR1-S845A mutation abolished morphine-regulated GluR1-containing 
AMPA receptor endocytosis (Fig. 3.25), the size of an intracellular receptor pool 
available for modifying synaptic strength may be smaller and/or the refilling may occur at 
a slower rate compared with that of WT. Hence, it is proposed that the GluR1-S845A 
mutants may show lower propensity to trigger reinsertion of AMPA receptors and/or 
initiate morphine-evoked synaptic plasticity such as LTP, resulting in different sensitivity 
in morphine CPP acquisition between the mutants and WTs. Further studies are needed 
to clarify whether the association between morphine and contextual stimuli can affect the 
levels of synaptic or intracellular GluR1-containing AMPA receptors and synaptic 
plasticity in hippocampus and compare the changing pattern of AMPA receptor 
expression between WT and the GluR1-S845A mutants. Apart from AMPA receptor 
trafficking, it should be noted that the long-lasting synaptic plasticity can also be caused 
by the drugs of abuse-evoked gene transcription and protein synthesis (Luscher and 
Malenka, 2011), which may be an alternative explanation why the GluR1-S845A 
  111 
mutation could not completely impair the acquisition of morphine CPP (Figs. 3.26 and 
3.29).  
 Previous genetic studies have demonstrated that the GluR1 knockout mice 
exhibited deficit in the extinction of cocaine CPP, revealing a prominent role of GluR1 in 
mediating the persistence of seeking behavior (Stephens and Mead, 2003; Engblom et 
al., 2008). Similarly, we observed a prolonged extinction of morphine CPP in the GluR1-
S845A mutants (Fig. 3.29). Thus, it provides direct evidence on the specific involvement 
of GluR1 phosphorylation and trafficking in the CPP extinction. The paradigm of CPP 
extinction, in which the environmental cue/conditioned stimulus was repeatedly 
presented in the drug-free state, results in progressive reduction in the CPP expression. 
In fact, the existing memory of drug reward-associated cue cannot be modified directly 
by extinction, instead it is suppressed by new learning of non-reward presentation that 
can compete with the original learning (Pavlov, 1924; Rescorla, 1996; Monfils et al., 
2009). Therefore, the impaired morphine extinction in GluR1-S845A mutants suggests 
that the S845A mutation may impair the learning of the new conditioning. Apart from the 
mechanism of extinction, the retrieval of the conditioned stimulus in the tests also 
engages an opposite mechanism called reconsolidation (Nader et al., 2000; Eisenberg 
et al., 2003, Lee et al., 2006). In the process of reconsolidation, the existing CPP 
memory upon retrieval transiently becomes labile and prone to modification, resulting in 
either enhancement or disruption of the existing memory (Tronson et al., 2006; Monfils 
et al., 2009; Schiller et al., 2010). A recent study has demonstrated that retrieval of 
conditioned stimulus leads to a transient endocytosis of AMPA receptors. Importantly, 
the blockade of the regulated AMPA receptor endocytosis prolonged the contextual fear 
response. These findings thus suggest that endocytosis of AMPA receptors triggers 
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synaptic changes for constraining the memory strength and so facilitating the loss of 
conditioned response (Rao-Ruiz et al., 2011). In our study, the GluR1-S845A mutation 
possibly attenuated the regulated endocytosis of AMPA receptors, which in turn may 
represent an alternative mechanism to induce prolonged extinction of morphine CPP by 
preventing the constraint on memory strength.  
 
4.5 Conclusion 
Incubation of cultured hippocampal neurons with morphine triggered calcineurin-
mediated dephosphorylation of GluR1 at Ser845, resulting in loss of both synaptic and 
extrasynaptic AMPA receptors through internalization. Importantly, this alteration in 
GluR1 phosphorylation at Ser845 and subsequent receptor endocytosis by morphine 
treatment are involved in the acquisition and extinction of morphine CPP, which 
suggests the involvement of AMPA receptor trafficking in the mechanisms underlying 
opiate-seeking behaviors.  
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